Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	json	split
Treatment of T lymphocytes with IFN - alpha, IL - 2, IL - 12, and IL - 15 upregulated IL - 2Ralpha, c - myc, and pim - 1 gene expression.	IL - 2,45,51,Protein	IL - 15,66,73,Protein	IL - 2Ralpha,86,98,Protein	c - myc,100,107,Protein	pim - 1,113,120,Protein	"[{""token"": ""IL - 2"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""IL - 15"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""IL - 2Ralpha"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Protein""}, {""token"": ""c - myc"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""pim - 1"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Protein""}]"	train
IFN - alpha enhanced tyrosine phosphorylation of STAT1, STAT3, STAT4, STAT5a, and STAT5b.	STAT1,49,54,Protein	STAT3,56,61,Protein	STAT4,63,68,Protein	STAT5a,70,76,Protein	STAT5b,82,88,Protein	"[{""token"": ""STAT1"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""STAT3"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""STAT4"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""STAT5a"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""STAT5b"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Protein""}]"	train
In this study, transient cotransfection of several GPIX promoter / reporter constructs into 293T kidney fibroblasts with a Fli - 1 expression vector shows that the oncogenic protein Fli - 1 can transactivate the GPIX promoter when an intact GPIX Ets site is present.	GPIX,51,55,Protein	Fli - 1,123,130,Protein	Fli - 1,182,189,Protein	GPIX,212,216,Protein	GPIX,241,245,Protein	"[{""token"": ""GPIX"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""Fli - 1"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""Fli - 1"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Protein""}, {""token"": ""GPIX"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Protein""}, {""token"": ""GPIX"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Protein""}]"	train
First, we showed that viral binding induced a number of immunoregulatory genes ( IL - 1beta, A20, NF - kappaB - p105 / p50, and IkappaBalpha) in unactivated monocytes and that neutralizing Abs to the major HCMV glycoproteins, gB ( UL55) and gH ( UL75), inhibited the induction of these genes.	IL - 1beta,81,91,Protein	A20,93,96,Protein	p105,112,116,Protein	p50,119,122,Protein	IkappaBalpha,128,140,Protein	"[{""token"": ""IL - 1beta"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Protein""}, {""token"": ""A20"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Protein""}]"	train
Extracellular - regulated kinase 1 / 2, Jun N - terminal kinase, and c - Jun are involved in NF - kappa B - dependent IL - 6 expression in human monocytes.	Extracellular - regulated kinase 1,0,34,Protein	2,37,38,Protein	Jun N - terminal kinase,40,63,Protein	c - Jun,69,76,Protein	IL - 6,118,124,Protein	"[{""token"": ""Extracellular - regulated kinase 1"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 37, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""Jun N - terminal kinase"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""c - Jun"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Protein""}]"	train
Despite this drastic effect in vivo, the in vitro immortalization of erythropoietin - dependent erythroid progenitors unexpectedly occurred at low frequency, and all four cell lines established expressed both erythrocytic ( globins) and megakaryocytic markers ( glycoprotein IIb, platelet factor 4) as well as Spi - 1 and Fli - 1 transcripts at permissive temperature.	erythropoietin,69,83,Protein	glycoprotein IIb,262,278,Protein	platelet factor 4,280,297,Protein	Spi - 1,310,317,Protein	Fli - 1,322,329,Protein	"[{""token"": ""erythropoietin"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""glycoprotein IIb"", ""start_span"": 262, ""end_span"": 278, ""type"": ""Protein""}, {""token"": ""platelet factor 4"", ""start_span"": 280, ""end_span"": 297, ""type"": ""Protein""}, {""token"": ""Spi - 1"", ""start_span"": 310, ""end_span"": 317, ""type"": ""Protein""}, {""token"": ""Fli - 1"", ""start_span"": 322, ""end_span"": 329, ""type"": ""Protein""}]"	train
The I gamma 3 ECS lies upstream of the major I gamma 3 transcription initiation site and displays more than 90% identity with the corresponding human I gamma 1, I gamma 2, and I gamma 4 regions.	I gamma 3,4,13,Protein	I gamma 3,45,54,Protein	I gamma 1,150,159,Protein	I gamma 2,161,170,Protein	I gamma 4,176,185,Protein	"[{""token"": ""I gamma 3"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Protein""}, {""token"": ""I gamma 3"", ""start_span"": 45, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""I gamma 1"", ""start_span"": 150, ""end_span"": 159, ""type"": ""Protein""}, {""token"": ""I gamma 2"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Protein""}, {""token"": ""I gamma 4"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Protein""}]"	train
These data indicate that thrombin activates endothelial ICAM - 1 expression and polymorphonuclear leukocyte adhesion by NF - kappa Bp65 binding to the downstream NF - kappa B site of ICAM - 1 promoter after proteolytically activated receptor - 1 activation.	thrombin,25,33,Protein	ICAM - 1,56,64,Protein	Bp65,131,135,Protein	ICAM - 1,183,191,Protein	proteolytically activated receptor - 1,207,245,Protein	"[{""token"": ""thrombin"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""Bp65"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Protein""}, {""token"": ""proteolytically activated receptor - 1"", ""start_span"": 207, ""end_span"": 245, ""type"": ""Protein""}]"	train
The signaling events that link FGF receptor - 1 engagement and NF - kappaB activation in Jurkat are probably distinct from the CD28 costimulation pathway, since FGF - 1 - induced Rel / kappaB binding proteins do not contain significant levels of c - Rel and are not identical with the CD28 response complex.	FGF receptor - 1,31,47,Protein	CD28,127,131,Protein	FGF - 1,161,168,Protein	c - Rel,246,253,Protein	CD28,285,289,Protein	"[{""token"": ""FGF receptor - 1"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""FGF - 1"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 285, ""end_span"": 289, ""type"": ""Protein""}]"	train
In early to intermediate stages of erythroid differentiation we monitored the induction of CD36, Tal1, EKLF, NF - E2, and GATA - 1 that preceeded expression of EpoR.	CD36,91,95,Protein	Tal1,97,101,Protein	EKLF,103,107,Protein	GATA - 1,122,130,Protein	EpoR,160,164,Protein	"[{""token"": ""CD36"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""Tal1"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""EKLF"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""GATA - 1"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""EpoR"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Protein""}]"	train
We have introduced a small deletion within beta - catenin ( Delta19) that disrupts binding to LEF - 1, E - cadherin, and APC but not axin.	beta - catenin,43,57,Protein	LEF - 1,94,101,Protein	E - cadherin,103,115,Protein	APC,121,124,Protein	axin,133,137,Protein	"[{""token"": ""beta - catenin"", ""start_span"": 43, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""LEF - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""E - cadherin"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""APC"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""axin"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Protein""}]"	train
We identified several genes up - regulated by IL - 12, namely, MIP - 1alpha, MIP - 1beta, IL - 1RA, and IFN regulatory factor - 1 ( IRF - 1).	MIP - 1alpha,63,75,Protein	MIP - 1beta,77,88,Protein	IL - 1RA,90,98,Protein	IFN regulatory factor - 1,104,129,Protein	IRF - 1,132,139,Protein	"[{""token"": ""MIP - 1alpha"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""MIP - 1beta"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""IL - 1RA"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Protein""}, {""token"": ""IFN regulatory factor - 1"", ""start_span"": 104, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""IRF - 1"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Protein""}]"	train
Inhibition of the NF - kappaB pathway by overexpression of a dominant - active inhibitor of NF - kappaB abolished CD40 - induced up - regulation of both the Bfl - 1 and Bcl - x genes and also eliminated the ability of CD40 to rescue Fas - induced cell death.	CD40,114,118,Protein	Bfl - 1,157,164,Protein	Bcl - x,169,176,Protein	CD40,218,222,Protein	Fas,233,236,Protein	"[{""token"": ""CD40"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""Bfl - 1"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Protein""}, {""token"": ""Bcl - x"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Protein""}, {""token"": ""Fas"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Protein""}]"	train
To determine the functionality of both the C / EBP - and GATA - binding sites, we analyzed whether C / EBPbeta and GATA - 1 can stimulate the MBP promoter in the C / EBPbeta and GATA - 1 negative Jurkat T - cell line.	C / EBPbeta,99,110,Protein	GATA - 1,115,123,Protein	MBP,142,145,Protein	C / EBPbeta,162,173,Protein	GATA - 1,178,186,Protein	"[{""token"": ""C / EBPbeta"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""GATA - 1"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""MBP"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""C / EBPbeta"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Protein""}, {""token"": ""GATA - 1"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Protein""}]"	train
TNF is the major inducer of NF - kappaB and particularly of the p50 - p65 complex, whereas IL - 7 acts as a cofactor by sustaining the expression of the p75 TNF receptor.	TNF,0,3,Protein	p50,64,67,Protein	p65,70,73,Protein	IL - 7,91,97,Protein	p75 TNF receptor,153,169,Protein	"[{""token"": ""TNF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""IL - 7"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""p75 TNF receptor"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Protein""}]"	train
To understand the function of AML1 during B cell differentiation, we analyzed regulatory regions of B cell - specific genes for potential AML1 - binding sites and have identified a putative AML1 - binding site in the promoter of the B cell - specific tyrosine kinase gene, blk.	AML1,30,34,Protein	AML1,138,142,Protein	AML1,190,194,Protein	B cell - specific tyrosine kinase,233,266,Protein	blk,273,276,Protein	"[{""token"": ""AML1"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""AML1"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Protein""}, {""token"": ""AML1"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""B cell - specific tyrosine kinase"", ""start_span"": 233, ""end_span"": 266, ""type"": ""Protein""}, {""token"": ""blk"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Protein""}]"	train
Physical interaction of AML1 with BSAP correlates with functional cooperativity in transfection studies where AML1 and BSAP synergistically activate blk promoter transcription by more than 50 - fold.	AML1,24,28,Protein	BSAP,34,38,Protein	AML1,110,114,Protein	BSAP,119,123,Protein	blk,149,152,Protein	"[{""token"": ""AML1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""BSAP"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""AML1"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""BSAP"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""blk"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Protein""}]"	train
Analysis of targets that could mediate these phenotypic changes indicated that c - Maf likely plays a key role in myeloid cell development through dual mechanisms; inhibition of a select set of c - Myb regulated targets, such as Bcl - 2 and CD13 / APN, coupled with the activation of as yet undefined differentiation - promoting genes.	c - Maf,79,86,Protein	c - Myb,194,201,Protein	Bcl - 2,229,236,Protein	CD13,241,245,Protein	APN,248,251,Protein	"[{""token"": ""c - Maf"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""c - Myb"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Protein""}, {""token"": ""CD13"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Protein""}, {""token"": ""APN"", ""start_span"": 248, ""end_span"": 251, ""type"": ""Protein""}]"	train
We have recently shown that the expression of Tax protected the mouse T - cell line CTLL - 2 against apoptosis induced by interleukin - 2 ( IL - 2) deprivation and converted its growth from being IL - 2 dependent to being IL - 2 independent.	Tax,46,49,Protein	interleukin - 2,122,137,Protein	IL - 2,140,146,Protein	IL - 2,196,202,Protein	IL - 2,222,228,Protein	"[{""token"": ""Tax"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Protein""}]"	train
These two DNA - protein complexes are composed of at least four host proteins ( p50, p55, p75, p85), each of which shares structural similarity with the v - rel oncogene product.	p50,80,83,Protein	p55,85,88,Protein	p75,90,93,Protein	p85,95,98,Protein	v - rel,153,160,Protein	"[{""token"": ""p50"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""p55"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""p75"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""p85"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Protein""}, {""token"": ""v - rel"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Protein""}]"	train
In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.	glucose oxidase,33,48,Protein	p75,70,73,Protein	p85,78,81,Protein	p50,109,112,Protein	p55,117,120,Protein	"[{""token"": ""glucose oxidase"", ""start_span"": 33, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""p75"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""p85"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Protein""}, {""token"": ""p55"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Protein""}]"	train
Okadaic acid treatment was found to dramatically increase mRNA transcripts of the jun family of proto - oncogenes including c - jun, junD, and junB and to a lesser extent the fos family including c - fos and fra - 1.	c - jun,124,131,Protein	junD,133,137,Protein	junB,143,147,Protein	c - fos,196,203,Protein	fra - 1,208,215,Protein	"[{""token"": ""c - jun"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""junD"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""junB"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""c - fos"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Protein""}, {""token"": ""fra - 1"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Protein""}]"	train
TCF - 1 alpha, originally identified and purified through its binding sites on the HIV - 1 promoter, was found to bind to the TCR alpha enhancer and to promoters for several genes expressed at significantly earlier stages of T - cell development than the TCR alpha gene ( e. g., p56lck and CD3 delta).	TCF - 1 alpha,0,13,Protein	TCR alpha,126,135,Protein	TCR alpha,255,264,Protein	p56lck,279,285,Protein	CD3 delta,290,299,Protein	"[{""token"": ""TCF - 1 alpha"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Protein""}, {""token"": ""TCR alpha"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""TCR alpha"", ""start_span"": 255, ""end_span"": 264, ""type"": ""Protein""}, {""token"": ""p56lck"", ""start_span"": 279, ""end_span"": 285, ""type"": ""Protein""}, {""token"": ""CD3 delta"", ""start_span"": 290, ""end_span"": 299, ""type"": ""Protein""}]"	train
Thus, the transcriptional activity of TCF - 1 alpha appears to depend on the TCF - 2 alpha and T alpha 1 ( CREB) transcription factors and the context of its binding site within the TCR alpha enhancer.	TCF - 1 alpha,38,51,Protein	TCF - 2 alpha,77,90,Protein	T alpha 1,95,104,Protein	CREB,107,111,Protein	TCR alpha,182,191,Protein	"[{""token"": ""TCF - 1 alpha"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""TCF - 2 alpha"", ""start_span"": 77, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""T alpha 1"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Protein""}, {""token"": ""CREB"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""TCR alpha"", ""start_span"": 182, ""end_span"": 191, ""type"": ""Protein""}]"	train
Because insertion mutations in phoP are polar on phoQ, we constructed strains that expressed the PhoQ protein in the absence of PhoP to test whether resistance to defensin requires only the phoQ gene product.	phoP,31,35,Protein	phoQ,49,53,Protein	PhoQ,97,101,Protein	PhoP,128,132,Protein	phoQ,190,194,Protein	"[{""token"": ""phoP"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""phoQ"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""PhoQ"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""PhoP"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""phoQ"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Protein""}]"	train
CD14 Sp1 site oligonucleotides bound preferentially to a 105 - kDa Sp1 species, which is present in higher relative levels in monocytic than non - monocytic cells, suggesting that modification of Sp1, such as phosphorylation, may explain how the Sp1 site mediates monocytic specific promoter activity.	CD14,0,4,Protein	Sp1,5,8,Protein	Sp1,67,70,Protein	Sp1,196,199,Protein	Sp1,246,249,Protein	"[{""token"": ""CD14"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Protein""}]"	train
BACKGROUND: The induction of vascular cell adhesion molecule - 1 ( VCAM - 1) and E - selectin by tumor necrosis factor - alpha ( TNF) is mediated by mobilization of the transcription factor nuclear factor - kappa B ( NF - kappa B).	vascular cell adhesion molecule - 1,29,64,Protein	VCAM - 1,67,75,Protein	E - selectin,81,93,Protein	tumor necrosis factor - alpha,97,126,Protein	TNF,129,132,Protein	"[{""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 29, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""E - selectin"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 97, ""end_span"": 126, ""type"": ""Protein""}, {""token"": ""TNF"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Protein""}]"	train
Induction of VCAM - 1 and E - selectin surface expression by TNF was dose - dependently reduced by aspirin over the same range, while induction of intercellular adhesion molecule - 1 ( ICAM - 1) was hardly affected.	VCAM - 1,13,21,Protein	E - selectin,26,38,Protein	TNF,61,64,Protein	intercellular adhesion molecule - 1,147,182,Protein	ICAM - 1,185,193,Protein	"[{""token"": ""VCAM - 1"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Protein""}, {""token"": ""E - selectin"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""TNF"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 147, ""end_span"": 182, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Protein""}]"	train
This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after stimulation by either IL - 1 alpha, IL - 1 beta, IL - 4, tumor necrosis factor ( TNF alpha), or bacterial lipopolysaccharide.	IL - 1 alpha,200,212,Protein	IL - 1 beta,214,225,Protein	IL - 4,227,233,Protein	tumor necrosis factor,235,256,Protein	TNF alpha,259,268,Protein	"[{""token"": ""IL - 1 alpha"", ""start_span"": 200, ""end_span"": 212, ""type"": ""Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 214, ""end_span"": 225, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 235, ""end_span"": 256, ""type"": ""Protein""}, {""token"": ""TNF alpha"", ""start_span"": 259, ""end_span"": 268, ""type"": ""Protein""}]"	train
Maximal increase in IL - 2 transcription was recorded with CHO - DR / B7 / LFA - 3, suggesting a cooperative effect of B7 and LFA - 3 at the transcriptional level.	IL - 2,20,26,Protein	B7,70,72,Protein	LFA - 3,75,82,Protein	B7,119,121,Protein	LFA - 3,126,133,Protein	"[{""token"": ""IL - 2"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""B7"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""LFA - 3"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""B7"", ""start_span"": 119, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""LFA - 3"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Protein""}]"	train
The AP - 1 binding proteins contained c - Jun, Jun - D, and Fra - 1, but marginal amounts of Jun - B and c - Fos.	c - Jun,38,45,Protein	Jun - D,47,54,Protein	Fra - 1,60,67,Protein	Jun - B,93,100,Protein	c - Fos,105,112,Protein	"[{""token"": ""c - Jun"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""Jun - D"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""Fra - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""Jun - B"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""c - Fos"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Protein""}]"	train
This action of the phosphatase inhibitors, which is associated with the activation of the RelA. p50 NF - kappa B heterodimer, is not affected by agents that block the induction of I kappa B alpha phosphorylation by tumor necrosis factor alpha ( TNF - alpha).	RelA,90,94,Protein	p50,96,99,Protein	I kappa B alpha,180,195,Protein	tumor necrosis factor alpha,215,242,Protein	TNF - alpha,245,256,Protein	"[{""token"": ""RelA"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 180, ""end_span"": 195, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 215, ""end_span"": 242, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Protein""}]"	train
Coexpression of HMG I / Y and Oct - 2 in cell lines lacking Oct - 2 results in high levels of HLA - DRA gene expression, and in vitro DNA - binding studies reveal that HMG I / Y stimulates Oct - 2A binding to the HLA - DRA promoter.	I / Y,20,25,Protein	Oct - 2,30,37,Protein	Oct - 2,60,67,Protein	I / Y,172,177,Protein	Oct - 2A,189,197,Protein	"[{""token"": ""I / Y"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""Oct - 2"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""Oct - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""I / Y"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Protein""}]"	train
Biochemical studies demonstrate that OBF - 1 has no intrinsic DNA - binding activity and recognizes the POU domains of Oct - 1 and Oct - 2, but not those of Oct - 4 and Oct - 6.	OBF - 1,37,44,Protein	Oct - 1,119,126,Protein	Oct - 2,131,138,Protein	Oct - 4,157,164,Protein	Oct - 6,169,176,Protein	"[{""token"": ""OBF - 1"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""Oct - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Protein""}, {""token"": ""Oct - 2"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""Oct - 4"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Protein""}, {""token"": ""Oct - 6"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Protein""}]"	train
Secretion of IL - 2 and TNF - alpha, surface expression of IL - 2R, and DNA - binding activity of NF - kappa B and AP - 1 ( Fos / Jun) complex in response to phorbol myristate acetate, TNF - alpha, or immobilized antibodies to CD3 were monitored.	IL - 2,13,19,Protein	TNF - alpha,24,35,Protein	Fos,124,127,Protein	Jun,130,133,Protein	TNF - alpha,185,196,Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""Fos"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Protein""}, {""token"": ""Jun"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Protein""}]"	train
We further demonstrate that Tax induction of nuclear c - Rel expression is activated by the RelA ( p65) subunit of NF - kappa B, which activates transcription of the c - rel gene through an intrinsic kappa B enhancer element.	Tax,28,31,Protein	c - Rel,53,60,Protein	RelA,92,96,Protein	p65,99,102,Protein	c - rel,166,173,Protein	"[{""token"": ""Tax"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""c - rel"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Protein""}]"	train
In contrast, the addition of GM - CSF to the M - TAT / EPO cell culture decreased the amount of hemoglobin, even in the presence of EPO, indicating that the EPO signal for erythroid differentiation is suppressed by GM - CSF.	GM - CSF,29,37,Protein	EPO,55,58,Protein	EPO,132,135,Protein	EPO,157,160,Protein	GM - CSF,215,223,Protein	"[{""token"": ""GM - CSF"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""EPO"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""EPO"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""EPO"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 215, ""end_span"": 223, ""type"": ""Protein""}]"	train
In this paper, we report that cross - linking of CD28 ( but not CD2, CD5, LFA - 1, or CD7) leads to an elevation of c - jun mRNA, with only minimal activation of c - fos expression.	CD28,49,53,Protein	CD5,69,72,Protein	CD7,86,89,Protein	c - jun,116,123,Protein	c - fos,162,169,Protein	"[{""token"": ""CD28"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""CD5"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""CD7"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""c - jun"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""c - fos"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Protein""}]"	train
Upon transfection into Nb2 T cells, 1. 7 kilobases ( kb) of IRF - 1 5 ' - flanking DNA linked to a chloramphenicol acetyl transferase ( CAT) reporter gene mediated a 30 - fold induction of CAT enzyme activity in response to 24 h of PRL stimulation.	IRF - 1,60,67,Protein	chloramphenicol acetyl transferase,99,133,Protein	CAT,136,139,Protein	CAT,189,192,Protein	PRL,232,235,Protein	"[{""token"": ""IRF - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""chloramphenicol acetyl transferase"", ""start_span"": 99, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""CAT"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""CAT"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Protein""}, {""token"": ""PRL"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Protein""}]"	train
By assaying CAT enzyme activity across a 24 - h PRL induction time course, we were able to assign G1 vs. S phase PRL responses of the IRF - 1 gene to different regions of the IRF - 1 5 ' - flanking and promoter DNA.	CAT,12,15,Protein	PRL,48,51,Protein	PRL,113,116,Protein	IRF - 1,134,141,Protein	IRF - 1,175,182,Protein	"[{""token"": ""CAT"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Protein""}, {""token"": ""PRL"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""PRL"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""IRF - 1"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""IRF - 1"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Protein""}]"	train
We focused our studies on the role of Pit - 1 and of PR as potential transcriptional regulators, since the POU domain protein Pit - 1 is essential in the control of pituitary PRL expression, and progesterone induces decidual transformation of the endometrial stroma, a differentiation process during which the decidual PRL gene is activated.	Pit - 1,38,45,Protein	PR,53,55,Protein	Pit - 1,126,133,Protein	PRL,175,178,Protein	PRL,319,322,Protein	"[{""token"": ""Pit - 1"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""PR"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""Pit - 1"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""PRL"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Protein""}, {""token"": ""PRL"", ""start_span"": 319, ""end_span"": 322, ""type"": ""Protein""}]"	train
Temporal analysis of the IL - 4 down - regulatory effect on the IL - 2 -, IL - 3 -, or GM - CSF - induced proinflammatory cytokine gene expression in monocytes provided evidence that IL - 4 acts predominantly on the post - transcriptional level.	IL - 4,25,31,Protein	IL - 2,64,70,Protein	IL - 3,74,80,Protein	GM - CSF,87,95,Protein	IL - 4,183,189,Protein	"[{""token"": ""IL - 4"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""IL - 3"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Protein""}]"	train
IL - 4 did not exert significant influence on the induction of expression of IL - 1 - RA or various CSFs by IL - 2, IL - 3, and GM - CSF.	IL - 4,0,6,Protein	IL - 1 - RA,77,88,Protein	IL - 2,108,114,Protein	IL - 3,116,122,Protein	GM - CSF,128,136,Protein	"[{""token"": ""IL - 4"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Protein""}, {""token"": ""IL - 1 - RA"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""IL - 3"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Protein""}]"	train
Both stimuli induced the appearance of the NF - kappa B components ( c - Rel, p65 ( RelA), and p50 ( NF - kappa B1)) and NF - kappa B DNA binding activity in the nucleus.	c - Rel,69,76,Protein	p65,78,81,Protein	RelA,84,88,Protein	p50,95,98,Protein	NF - kappa B1,101,114,Protein	"[{""token"": ""c - Rel"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Protein""}]"	train
We demonstrate that the staphylococcal superantigens toxic shock syndrome toxin - 1 ( TSST - 1) and staphylococcal enterotoxin A ( SEA) activate HIV - 1 - LTR - driven transcription of chloramphenicol acetyl transferase in the human monocytic cell line THP - 1.	toxic shock syndrome toxin - 1,53,83,Protein	TSST - 1,86,94,Protein	staphylococcal enterotoxin A,100,128,Protein	SEA,131,134,Protein	chloramphenicol acetyl transferase,185,219,Protein	"[{""token"": ""toxic shock syndrome toxin - 1"", ""start_span"": 53, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""TSST - 1"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""staphylococcal enterotoxin A"", ""start_span"": 100, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""SEA"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""chloramphenicol acetyl transferase"", ""start_span"": 185, ""end_span"": 219, ""type"": ""Protein""}]"	train
Electrophoretic mobility supershift assays determine that members of the NF - kappa B / Rel family of transcription factors can bind to this site in vitro and that DNA - binding complexes that contain p50, p52, p65, and cRel correlate with positive regulation whereas the presence of p50 correlates with negative regulation.	p50,201,204,Protein	p52,206,209,Protein	p65,211,214,Protein	cRel,220,224,Protein	p50,284,287,Protein	"[{""token"": ""p50"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Protein""}, {""token"": ""p52"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Protein""}, {""token"": ""cRel"", ""start_span"": 220, ""end_span"": 224, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Protein""}]"	train
The Pan gene encodes at least two distinct transcripts, Pan - 1 and Pan - 2 ( also known as E47 and E12, respectively), by the mechanism of alternative RNA splicing.	Pan,4,7,Protein	Pan - 1,56,63,Protein	Pan - 2,68,75,Protein	E47,92,95,Protein	E12,100,103,Protein	"[{""token"": ""Pan"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""Pan - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""Pan - 2"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""E47"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""E12"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Protein""}]"	train
In contrast to previous results obtained using polyclonal antiseras to detect Pan / E2A proteins, we report comparable levels of Pan proteins in GH / PRL - and insulin - producing, B - and T - lymphocyte cells.	Pan,78,81,Protein	E2A,84,87,Protein	Pan,129,132,Protein	GH,145,147,Protein	insulin,160,167,Protein	"[{""token"": ""Pan"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""E2A"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""Pan"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""GH"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""insulin"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Protein""}]"	train
In fact, under low - ionic - strength conditions, the TF complex did not migrate with translated p50 / p65 dimers but instead comigrated with c - Rel / p65 dimers.	TF,54,56,Protein	p50,97,100,Protein	p65,103,106,Protein	c - Rel,142,149,Protein	p65,152,155,Protein	"[{""token"": ""TF"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Protein""}]"	train
TSH - R expression levels were variable, but displayed a close correlation to the expression of thyroid peroxidase ( r = 0. 703; P < 0. 05), thyroglobulin ( r = 0. 817; P < 0. 01), and the nuclear oncogene c - fos ( r = 0. 935; P < 0. 001), but not c - myc.	TSH - R,0,7,Protein	thyroid peroxidase,96,114,Protein	thyroglobulin,141,154,Protein	c - fos,206,213,Protein	c - myc,249,256,Protein	"[{""token"": ""TSH - R"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""thyroid peroxidase"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""thyroglobulin"", ""start_span"": 141, ""end_span"": 154, ""type"": ""Protein""}, {""token"": ""c - fos"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Protein""}, {""token"": ""c - myc"", ""start_span"": 249, ""end_span"": 256, ""type"": ""Protein""}]"	train
To elucidate the roles of individual GATA factors in erythropoiesis, conditional alleles of GATA - 1, GATA - 2, and GATA - 3 were prepared by fusing each of the factors to the hormone - binding domain of the human estrogen receptor ( ER).	GATA - 1,92,100,Protein	GATA - 2,102,110,Protein	GATA - 3,116,124,Protein	estrogen receptor,214,231,Protein	ER,234,236,Protein	"[{""token"": ""GATA - 1"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""GATA - 2"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""GATA - 3"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""estrogen receptor"", ""start_span"": 214, ""end_span"": 231, ""type"": ""Protein""}, {""token"": ""ER"", ""start_span"": 234, ""end_span"": 236, ""type"": ""Protein""}]"	train
In order to understand the relationship, if any, between expression of GATA - 1, response to Epo and erythroid differentiation, we analyzed the expression of GATA - 1, Epo - R and globin genes in an Epo - dependent human cell line, UT - 7 Epo.	GATA - 1,71,79,Protein	Epo,93,96,Protein	GATA - 1,158,166,Protein	Epo - R,168,175,Protein	Epo,199,202,Protein	"[{""token"": ""GATA - 1"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""Epo"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""GATA - 1"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Protein""}, {""token"": ""Epo - R"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Protein""}, {""token"": ""Epo"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Protein""}]"	train
Expression of the MAP kinase - specific phosphatase, MKP - 1, which blocks ERK activation, inhibited IL - 2 promoter and NF - AT - driven transcription stimulated by a calcium ionophore and PMA, and in addition, MKP - 1 neutralized the transcriptional enhancement caused by active Raf - 1 and MEK1 expression.	MKP - 1,53,60,Protein	IL - 2,101,107,Protein	MKP - 1,212,219,Protein	Raf - 1,281,288,Protein	MEK1,293,297,Protein	"[{""token"": ""MKP - 1"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""MKP - 1"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Protein""}, {""token"": ""Raf - 1"", ""start_span"": 281, ""end_span"": 288, ""type"": ""Protein""}, {""token"": ""MEK1"", ""start_span"": 293, ""end_span"": 297, ""type"": ""Protein""}]"	train
We conclude that the MAP kinase signal transduction pathway consisting of Raf - 1, MEK1, and ERK1 and ERK2 functions in the stimulation IL - 2 gene transcription in activated T lymphocytes.	Raf - 1,74,81,Protein	MEK1,83,87,Protein	ERK1,93,97,Protein	ERK2,102,106,Protein	IL - 2,136,142,Protein	"[{""token"": ""Raf - 1"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""MEK1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""ERK1"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""ERK2"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Protein""}]"	train
A mutant Tax protein deficient in transactivation of genes by the nuclear factor ( NF) - kappaB pathway was unable to induce transcriptional activity of IL - 1alpha promoter - CAT constructs, but was rescued by exogenous provision of p65 / p50 NF - kappaB.	Tax,9,12,Protein	IL - 1alpha,153,164,Protein	CAT,176,179,Protein	p65,234,237,Protein	p50,240,243,Protein	"[{""token"": ""Tax"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""IL - 1alpha"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Protein""}, {""token"": ""CAT"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Protein""}]"	train
Despite the dual specificity of HTLV - 1 Tax for IkappaBalpha and IkappaBbeta at the protein level, Tax selectively stimulates NF - kappaB - directed transcription of the IkappaBalpha gene.	Tax,41,44,Protein	IkappaBalpha,49,61,Protein	IkappaBbeta,66,77,Protein	Tax,100,103,Protein	IkappaBalpha,171,183,Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""Tax"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 171, ""end_span"": 183, ""type"": ""Protein""}]"	train
STAT5 - and STAT1 - related factors were detected in ALL and STAT1 -, STAT3 -, and STAT5 - related proteins were present in nuclear cell extracts from AML.	STAT5,0,5,Protein	STAT1,12,17,Protein	STAT1,61,66,Protein	STAT3,70,75,Protein	STAT5,83,88,Protein	"[{""token"": ""STAT5"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Protein""}, {""token"": ""STAT3"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""STAT5"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Protein""}]"	train
hLH - 2 was mapped to chromosome 9Q33 - 34. 1, in the same region as the reciprocal translocation that creates the BCR - ABL chimera of the Philadelphia chromosome ( Ph '), the hallmark of CML; hLH - 2 was retained on the derivative 9 chromosome and is therefore centromeric of c - ABL.	hLH - 2,0,7,Protein	BCR,115,118,Protein	ABL,121,124,Protein	hLH - 2,194,201,Protein	c - ABL,278,285,Protein	"[{""token"": ""hLH - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""BCR"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""ABL"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""hLH - 2"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""c - ABL"", ""start_span"": 278, ""end_span"": 285, ""type"": ""Protein""}]"	train
The gammac chain is a subunit of multiple cytokine receptors ( interleukin ( IL) - 2, IL - 4, IL - 7, IL - 9, and IL - 15), the expression of which is restricted to hematopoietic lineages.	gammac,4,10,Protein	IL - 4,86,92,Protein	IL - 7,94,100,Protein	IL - 9,102,108,Protein	IL - 15,114,121,Protein	"[{""token"": ""gammac"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""IL - 7"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""IL - 9"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Protein""}, {""token"": ""IL - 15"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Protein""}]"	train
The identification of oriP and the EBNA2 - dependent enhancer as the major positive cis elements involved in regulating Cp activity in LCL suggests that EBNA gene transcription is largely autoregulated by EBNA 1 and EBNA 2.	oriP,22,26,Protein	EBNA2,35,40,Protein	Cp,120,122,Protein	EBNA 1,205,211,Protein	EBNA 2,216,222,Protein	"[{""token"": ""oriP"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""EBNA2"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""Cp"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""EBNA 1"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Protein""}, {""token"": ""EBNA 2"", ""start_span"": 216, ""end_span"": 222, ""type"": ""Protein""}]"	train
Finally, potential targets of regulation by the zinc - finger transcription factor encoded by egr - 1 include the interleukin - 2, CD44, ICAM - 1, and tumor necrosis factor genes.	egr - 1,94,101,Protein	interleukin - 2,114,129,Protein	CD44,131,135,Protein	ICAM - 1,137,145,Protein	tumor necrosis factor,151,172,Protein	"[{""token"": ""egr - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 114, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""CD44"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 151, ""end_span"": 172, ""type"": ""Protein""}]"	train
The cytokines IFN - beta, IFN - gamma, IL - 4, and LPS, although unable to induce sialoadhesin expression by themselves, were able to enhance GC - mediated induction of sialoadhesin.	IFN - beta,14,24,Protein	IFN - gamma,26,37,Protein	IL - 4,39,45,Protein	sialoadhesin,82,94,Protein	sialoadhesin,169,181,Protein	"[{""token"": ""IFN - beta"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Protein""}]"	train
To better understand the contribution of the GR N - terminal transactivation domain in mediating murine thymocyte apoptosis, we stably transfected GR, GR variants, and the androgen receptor ( AR) into receptor - negative S49 murine thymoma cells.	GR,45,47,Protein	GR,147,149,Protein	GR,151,153,Protein	androgen receptor,172,189,Protein	AR,192,194,Protein	"[{""token"": ""GR"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""GR"", ""start_span"": 147, ""end_span"": 149, ""type"": ""Protein""}, {""token"": ""GR"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""androgen receptor"", ""start_span"": 172, ""end_span"": 189, ""type"": ""Protein""}, {""token"": ""AR"", ""start_span"": 192, ""end_span"": 194, ""type"": ""Protein""}]"	train
We found that GIG18 was rapidly induced to comparable levels by both AR and GR, demonstrating that AR can indeed function as a transcriptional activator in S49 cells and, moreover, that GIG18 induction may be a marker of early apoptotic events in steroid - treated cells.	GIG18,14,19,Protein	AR,69,71,Protein	GR,76,78,Protein	AR,99,101,Protein	GIG18,186,191,Protein	"[{""token"": ""GIG18"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Protein""}, {""token"": ""AR"", ""start_span"": 69, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""GR"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""AR"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""GIG18"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Protein""}]"	train
Analysis of the accumulation of mRNA - encoding members of the AP - 1 transcription factor family demonstrated that c - fos and junB are also expressed upon stimulation of NK and T cells with IL - 2, but not IL - 12, whereas expression of c - jun and junD is not modified by either cytokine.	c - fos,116,123,Protein	junB,128,132,Protein	IL - 2,192,198,Protein	c - jun,239,246,Protein	junD,251,255,Protein	"[{""token"": ""c - fos"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""junB"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Protein""}, {""token"": ""c - jun"", ""start_span"": 239, ""end_span"": 246, ""type"": ""Protein""}, {""token"": ""junD"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Protein""}]"	train
The effect of both cytokines on the monocyte maturation / differentiation ( CD11b, CD13, and CD26) and other macrophage markers ( CD14 and CD68) was examined.	CD11b,76,81,Protein	CD13,83,87,Protein	CD26,93,97,Protein	CD14,130,134,Protein	CD68,139,143,Protein	"[{""token"": ""CD11b"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""CD13"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""CD26"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""CD14"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""CD68"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Protein""}]"	train
Whereas T cells from young subjects stimulated with cross - linked anti - CD3epsilon mAb OKT3 plus PMA or with the lectin PHA plus PMA demonstrated considerable increases in c - Fos protein expression, the expression of c - Fos but not c - Jun was markedly reduced in stimulated T cells from certain elderly subjects.	CD3epsilon,74,84,Protein	PHA,122,125,Protein	c - Fos,174,181,Protein	c - Fos,220,227,Protein	c - Jun,236,243,Protein	"[{""token"": ""CD3epsilon"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Protein""}, {""token"": ""PHA"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""c - Fos"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Protein""}, {""token"": ""c - Fos"", ""start_span"": 220, ""end_span"": 227, ""type"": ""Protein""}, {""token"": ""c - Jun"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Protein""}]"	train
Freshly isolated monocytes constitutively expressed high levels of transcriptionally inactive p50 homodimer which decreased with time in culture in favor of the transcriptionally active p50 / p65 and p50 / RelB heterodimers.	p50,94,97,Protein	p50,186,189,Protein	p65,192,195,Protein	p50,200,203,Protein	RelB,206,210,Protein	"[{""token"": ""p50"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Protein""}]"	train
TRAMP, a novel apoptosis - mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas ( Apo - 1 / CD95).	TRAMP,0,5,Protein	tumor necrosis factor receptor 1,72,104,Protein	Fas,109,112,Protein	Apo - 1,115,122,Protein	CD95,125,129,Protein	"[{""token"": ""TRAMP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor receptor 1"", ""start_span"": 72, ""end_span"": 104, ""type"": ""Protein""}, {""token"": ""Fas"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Protein""}, {""token"": ""Apo - 1"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""CD95"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Protein""}]"	train
Characterization of the NF - kappa B1 promoter identified an Egr - 1 site which was found to be essential for both the PMA / PHA - mediated induction as well as the synergistic activation observed after the expression of the RelA subunit of NF - kappa B and Egr - 1.	NF - kappa B1,24,37,Protein	Egr - 1,61,68,Protein	PHA,125,128,Protein	RelA,225,229,Protein	Egr - 1,258,265,Protein	"[{""token"": ""NF - kappa B1"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""Egr - 1"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""PHA"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 225, ""end_span"": 229, ""type"": ""Protein""}, {""token"": ""Egr - 1"", ""start_span"": 258, ""end_span"": 265, ""type"": ""Protein""}]"	train
Furthermore, Egr - 1 induction was required for endogenous NF - kappa B1 gene expression, since PMA / PHA - stimulated T cell lines expressing antisense Egr - 1 RNA were inhibited in their ability to upregulate NF - kappa B1 transcription.	Egr - 1,13,20,Protein	NF - kappa B1,59,72,Protein	PHA,102,105,Protein	Egr - 1,153,160,Protein	NF - kappa B1,211,224,Protein	"[{""token"": ""Egr - 1"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""PHA"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""Egr - 1"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 211, ""end_span"": 224, ""type"": ""Protein""}]"	train
The human TF promoter contains binding sites for the transcription factors AP - 1, c - Rel / p65, Egr - 1, and Sp1.	TF,10,12,Protein	c - Rel,83,90,Protein	p65,93,96,Protein	Egr - 1,98,105,Protein	Sp1,111,114,Protein	"[{""token"": ""TF"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""Egr - 1"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Protein""}]"	train
NO is produced from at least three different NO synthase ( NOS) isoforms: neuronal NOS ( nNOS), endothelial NOS, and immunologic NOS ( iNOS).	neuronal NOS,74,86,Protein	nNOS,89,93,Protein	endothelial NOS,96,111,Protein	immunologic NOS,117,132,Protein	iNOS,135,139,Protein	"[{""token"": ""neuronal NOS"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""nNOS"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""endothelial NOS"", ""start_span"": 96, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""immunologic NOS"", ""start_span"": 117, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""iNOS"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Protein""}]"	train
Interleukin - 2 ( IL - 2) promoter activity stimulated by cross - linking of CD2, TCR / CD3, and CD28 with antibodies was significantly reduced by transient expression of an Itk mutant lacking the kinase activity.	Interleukin - 2,0,15,Protein	IL - 2,18,24,Protein	CD2,77,80,Protein	CD28,97,101,Protein	Itk,174,177,Protein	"[{""token"": ""Interleukin - 2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""Itk"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Protein""}]"	train
These results demonstrate that Itk plays a role in IL - 2 production, indicating a critical involvement of Itk in the initial stage of T cell activation by mediating signals from the TCR / CD3 complex, CD2, and CD28.	Itk,31,34,Protein	IL - 2,51,57,Protein	Itk,107,110,Protein	CD2,202,205,Protein	CD28,211,215,Protein	"[{""token"": ""Itk"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""Itk"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Protein""}]"	train
Cyclin A was observed after 4 days of costimulation with anti CD2 + CD28 whereas stimulation by anti CD2 or anti CD28 alone was not effective.	Cyclin A,0,8,Protein	CD2,62,65,Protein	CD28,68,72,Protein	CD2,101,104,Protein	CD28,113,117,Protein	"[{""token"": ""Cyclin A"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Protein""}]"	train
Prolactin activates Stat5, and interleukin - 4 ( IL - 4) activates Stat6.	Prolactin,0,9,Protein	Stat5,20,25,Protein	interleukin - 4,31,46,Protein	IL - 4,49,55,Protein	Stat6,67,72,Protein	"[{""token"": ""Prolactin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Protein""}, {""token"": ""Stat5"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""interleukin - 4"", ""start_span"": 31, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""Stat6"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Protein""}]"	train
Fab fragment of anti - E. chaffeensis immunoglobulin G complexed with E. chaffeensis did not induce any of these three cytokines, indicating that ehrlichial binding is required for IL - 1beta mRNA expression and that binding of the immune complex to the Fc gamma receptor is required for TNF - alpha and IL - 6 mRNA expression and enhanced IL - 1beta mRNA expression.	IL - 1beta,181,191,Protein	Fc gamma receptor,254,271,Protein	TNF - alpha,288,299,Protein	IL - 6,304,310,Protein	IL - 1beta,340,350,Protein	"[{""token"": ""IL - 1beta"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Protein""}, {""token"": ""Fc gamma receptor"", ""start_span"": 254, ""end_span"": 271, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 288, ""end_span"": 299, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 304, ""end_span"": 310, ""type"": ""Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 340, ""end_span"": 350, ""type"": ""Protein""}]"	train
We also found that IL - 2 protects T cell clones from IL - 2 deprivation apoptosis accompanying active proliferation and enhanced expression of P53, Rb and Bcl - xL proteins.	IL - 2,19,25,Protein	IL - 2,54,60,Protein	P53,144,147,Protein	Rb,149,151,Protein	Bcl - xL,156,164,Protein	"[{""token"": ""IL - 2"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""P53"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""Rb"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Protein""}]"	train
Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding hepatocyte nuclear factor - 3alpha, - 3beta, - 3gamma, - 4gamma, and - 6.	hepatocyte nuclear factor - 3alpha,86,120,Protein	- 3beta,122,129,Protein	- 3gamma,131,139,Protein	- 4gamma,141,149,Protein	- 6,155,158,Protein	"[{""token"": ""hepatocyte nuclear factor - 3alpha"", ""start_span"": 86, ""end_span"": 120, ""type"": ""Protein""}, {""token"": ""- 3beta"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""- 3gamma"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""- 4gamma"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Protein""}, {""token"": ""- 6"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Protein""}]"	train
In this study, we show that HNF - 3alpha, - 3beta, - 3gamma, - 4gamma, and - 6 are expressed in pancreatic beta - cells.	HNF - 3alpha,28,40,Protein	- 3beta,42,49,Protein	- 3gamma,51,59,Protein	- 4gamma,61,69,Protein	- 6,75,78,Protein	"[{""token"": ""HNF - 3alpha"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""- 3beta"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""- 3gamma"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""- 4gamma"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Protein""}, {""token"": ""- 6"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Protein""}]"	train
These results indicate that CsA interferes with a specific event in the signal - induced degradation of I kappa B alpha and I kappa B beta, but does not affect the processing of NF - kappa B1 / p105 to p50.	I kappa B alpha,104,119,Protein	I kappa B beta,124,138,Protein	NF - kappa B1,178,191,Protein	p105,194,198,Protein	p50,202,205,Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 104, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 124, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Protein""}]"	train
Whereas mutations in the GATA - 3 site abolished antigen - or cAMP - stimulated IL - 5 promoter activation in Th2 cells, ectopic expression of GATA - 3 in Th1 cells or in a non - lymphoid, non - IL - 5 - producing cell line activated the IL - 5 promoter.	GATA - 3,25,33,Protein	IL - 5,80,86,Protein	GATA - 3,143,151,Protein	IL - 5,195,201,Protein	IL - 5,238,244,Protein	"[{""token"": ""GATA - 3"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Protein""}, {""token"": ""IL - 5"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""GATA - 3"", ""start_span"": 143, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""IL - 5"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""IL - 5"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Protein""}]"	train
Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 ( VCAM - 1), NAC inhibited IL - 1 beta - induced mRNA and cell surface expression of both E - selectin and VCAM - 1.	vascular cell adhesion molecule 1,87,120,Protein	VCAM - 1,123,131,Protein	IL - 1 beta,148,159,Protein	E - selectin,211,223,Protein	VCAM - 1,228,236,Protein	"[{""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 87, ""end_span"": 120, ""type"": ""Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Protein""}, {""token"": ""E - selectin"", ""start_span"": 211, ""end_span"": 223, ""type"": ""Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 228, ""end_span"": 236, ""type"": ""Protein""}]"	train
Further, Vpr suppresses expression of IL - 2, IL - 10, IL - 12, TNF alpha and IL - 4, all of which are NF - kappa B - dependent.	Vpr,9,12,Protein	IL - 2,38,44,Protein	IL - 10,46,53,Protein	TNF alpha,64,73,Protein	IL - 4,78,84,Protein	"[{""token"": ""Vpr"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""TNF alpha"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Protein""}]"	train
We also identified Sp1, Sp3, and NGFI - A / Egr - 1 as the primary nuclear transcription factors binding to TRE1 which mediate Tax responsiveness.	Sp1,19,22,Protein	Sp3,24,27,Protein	NGFI - A,33,41,Protein	Egr - 1,44,51,Protein	Tax,127,130,Protein	"[{""token"": ""Sp1"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Protein""}, {""token"": ""Sp3"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""NGFI - A"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""Egr - 1"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""Tax"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Protein""}]"	train
Anti - intercellular adhesion molecule - 1 ( ICAM - 1) and anti - P - selectin antibodies ( monoclonal antibodies [ mAbs]) attenuated phase - 1 neutrophil adhesion, consistent with roles for constitutively expressed ICAM - 1 and enhanced surface expression of preformed P - selectin.	intercellular adhesion molecule - 1,7,42,Protein	ICAM - 1,45,53,Protein	P - selectin,66,78,Protein	ICAM - 1,216,224,Protein	P - selectin,270,282,Protein	"[{""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 7, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""P - selectin"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Protein""}, {""token"": ""P - selectin"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Protein""}]"	train
Here we show that in E29. 1 T cell hybridoma I kappa B alpha and I kappa B beta are equally associated with p65 and that I kappa B beta is degraded in response to TNF alpha in contrast to what has been originally published.	I kappa B alpha,45,60,Protein	I kappa B beta,65,79,Protein	p65,108,111,Protein	I kappa B beta,121,135,Protein	TNF alpha,163,172,Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 45, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 121, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""TNF alpha"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Protein""}]"	train
A kappa B - site was identified in the promoter of the intercellular adhesion molecule - 1 ( ICAM - 1) gene, which is involved in regulation of ICAM - 1 expression by tumor necrosis factor alpha ( TNF - alpha) and glucocorticoids.	intercellular adhesion molecule - 1,55,90,Protein	ICAM - 1,93,101,Protein	ICAM - 1,144,152,Protein	tumor necrosis factor alpha,167,194,Protein	TNF - alpha,197,208,Protein	"[{""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 55, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 167, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Protein""}]"	train
In vitro, the ICAM - 1 kappa B site appeared to bind RelA and c - Rel homodimers as well as heterodimers with NF - kappa B1, but weakly NF - kappa B1 homodimers.	ICAM - 1,14,22,Protein	RelA,53,57,Protein	c - Rel,62,69,Protein	NF - kappa B1,110,123,Protein	NF - kappa B1,136,149,Protein	"[{""token"": ""ICAM - 1"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 136, ""end_span"": 149, ""type"": ""Protein""}]"	train
Full activity can be restored by the combined action of recombinant PC4 and the PC4 - depleted USA fraction, thus suggesting a joint requirement for PC4 and another, USA - derived component ( s) for optimal function of Oct - 1 / OCA - B in the reconstituted system.	PC4,68,71,Protein	PC4,80,83,Protein	PC4,149,152,Protein	Oct - 1,219,226,Protein	OCA - B,229,236,Protein	"[{""token"": ""PC4"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""PC4"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""PC4"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Protein""}, {""token"": ""Oct - 1"", ""start_span"": 219, ""end_span"": 226, ""type"": ""Protein""}, {""token"": ""OCA - B"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Protein""}]"	train
Inhibition of iNO synthase ( iNOS) activity with N omega - monomethyl - L - arginine in endothelial - RAW264. 7 cocultures, stimulated with murine - specific IFN - gamma and LPS, decreased iNO production by 86%, augmented VCAM - 1 and iNOS expression in endothelial and RAW264. 7 cells, respectively, and increased monocyte adhesion to the endothelial cell surface.	iNO synthase,14,26,Protein	iNOS,29,33,Protein	IFN - gamma,158,169,Protein	VCAM - 1,222,230,Protein	iNOS,235,239,Protein	"[{""token"": ""iNO synthase"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""iNOS"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Protein""}, {""token"": ""iNOS"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Protein""}]"	train
To elucidate the role of retinoic acid ( RA) in anti - CD40 + interleukin - 4 ( IL - 4) - mediated B - cell activation, the effect of 10 ( - 12) to 10 ( - 6) mol / L RA was studied in anti - CD40 ( 1 microgram / mL) + IL - 4 ( 5 ng / mL) - mediated proliferation and Ig synthesis by human peripheral blood mononuclear cells ( PBMC) and B cells in healthy donors.	CD40,55,59,Protein	interleukin - 4,62,77,Protein	IL - 4,80,86,Protein	CD40,191,195,Protein	IL - 4,218,224,Protein	"[{""token"": ""CD40"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""interleukin - 4"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 218, ""end_span"": 224, ""type"": ""Protein""}]"	train
Using Tax mutants that fail to activate either ATF - or NF - kappaB - dependent promoters and different 5 ' truncation mutants of the E2F - 1 promoter, we show that the Tax - dependent transcriptional control of the E2F1 gene involves, at least in part, the ATF binding site located in the E2F - 1 promoter.	Tax,6,9,Protein	E2F - 1,134,141,Protein	Tax,169,172,Protein	E2F1,216,220,Protein	E2F - 1,290,297,Protein	"[{""token"": ""Tax"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Protein""}, {""token"": ""E2F - 1"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""Tax"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Protein""}, {""token"": ""E2F1"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Protein""}, {""token"": ""E2F - 1"", ""start_span"": 290, ""end_span"": 297, ""type"": ""Protein""}]"	train
In contrast to induction of STATs by cytokines, the IRF - 1 GAS - binding complex activated by CD40, TNF - alpha, or EBV contains Rel proteins, specifically p50 and p65.	IRF - 1,52,59,Protein	CD40,95,99,Protein	TNF - alpha,101,112,Protein	p50,157,160,Protein	p65,165,168,Protein	"[{""token"": ""IRF - 1"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Protein""}]"	train
The molecular mechanisms by which IL - 4 induces expression of the IL - 4 gene are not known, although the IL - 4 - activated transcription factor signal transducer and activator of transcription 6 ( Stat6) is required for this effect.	IL - 4,34,40,Protein	IL - 4,67,73,Protein	IL - 4,107,113,Protein	signal transducer and activator of transcription 6,147,197,Protein	Stat6,200,205,Protein	"[{""token"": ""IL - 4"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Protein""}, {""token"": ""signal transducer and activator of transcription 6"", ""start_span"": 147, ""end_span"": 197, ""type"": ""Protein""}, {""token"": ""Stat6"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Protein""}]"	train
The aberrant CD4 ( -) CD8 ( -) T cells from lpr / lpr and gld / gld mice, which have mutations in the genes encoding Fas and FasL, respectively, have an activated phenotype and constitutively express high levels of fasL mRNA, prompting us to ask what role if any the FLRE and Egr family proteins have in this aberrant expression of fasL.	CD4,13,16,Protein	Fas,117,120,Protein	FasL,125,129,Protein	fasL,215,219,Protein	fasL,332,336,Protein	"[{""token"": ""CD4"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Protein""}, {""token"": ""Fas"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Protein""}, {""token"": ""FasL"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""fasL"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Protein""}, {""token"": ""fasL"", ""start_span"": 332, ""end_span"": 336, ""type"": ""Protein""}]"	train
Although overexpressed Egr - 1 was ineffective, overexpressed Egr - 2 was as potent as Egr - 3 in inducing fasL promoter - dependent reporter constructs in T cell hybridomas and HeLa cells, and both up - regulated endogenous fasL mRNA in HeLa cells.	Egr - 1,23,30,Protein	Egr - 2,62,69,Protein	Egr - 3,87,94,Protein	fasL,107,111,Protein	fasL,225,229,Protein	"[{""token"": ""Egr - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Protein""}, {""token"": ""Egr - 2"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Protein""}, {""token"": ""Egr - 3"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""fasL"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""fasL"", ""start_span"": 225, ""end_span"": 229, ""type"": ""Protein""}]"	train
Increased expression of wild - type NFAT1 substantially increases IL - 4 promoter activity in unprimed CD4 T cells, suggesting NFAT1 may be limiting for IL - 4 gene expression in this cell type.	NFAT1,36,41,Protein	IL - 4,66,72,Protein	CD4,103,106,Protein	NFAT1,127,132,Protein	IL - 4,153,159,Protein	"[{""token"": ""NFAT1"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""NFAT1"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Protein""}]"	train
The endothelial expression of vascular cell adhesion molecule - 1 ( VCAM - 1), E - selectin, and intercellular adhesion molecule - 1 was monitored by cell surface enzyme immunoassays or flow cytometry, and steady - state levels of VCAM - 1 mRNA were assessed by Northern blot analysis.	vascular cell adhesion molecule - 1,30,65,Protein	VCAM - 1,68,76,Protein	E - selectin,79,91,Protein	intercellular adhesion molecule - 1,97,132,Protein	VCAM - 1,231,239,Protein	"[{""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 30, ""end_span"": 65, ""type"": ""Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""E - selectin"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 97, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Protein""}]"	train
Phenotypic DC characteristics of KG1 dendritic - like cells include morphology ( loosely adherent cells with long neurite processes), MHC I + / MHC IIbright / CD83 + / CD86 + / CD14 - surface Ag expression, and RelB and DC - CK1 gene expression.	CD83,159,163,Protein	CD86,168,172,Protein	CD14,177,181,Protein	RelB,211,215,Protein	DC - CK1,220,228,Protein	"[{""token"": ""CD83"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""CD86"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Protein""}, {""token"": ""CD14"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Protein""}, {""token"": ""DC - CK1"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Protein""}]"	valid
CD40 expression could be enhanced in CD40 - positive MM by stimulation with IFN - gamma and tumor necrosis factor - alpha but not by interleukin ( IL) - 1beta or CD40 triggering.	CD40,0,4,Protein	CD40,37,41,Protein	IFN - gamma,76,87,Protein	tumor necrosis factor - alpha,92,121,Protein	CD40,162,166,Protein	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 92, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Protein""}]"	valid
In contrast, although the Janus kinase 3 tyrosine kinase was associated with CD40 molecules in both monocytes and resting B cells, Janus kinase 3 phosphorylation induction was observed only in CD40 - activated monocytes, with subsequent induction of STAT5a DNA binding activity in the nucleus.	Janus kinase 3,26,40,Protein	CD40,77,81,Protein	Janus kinase 3,131,145,Protein	CD40,193,197,Protein	STAT5a,250,256,Protein	"[{""token"": ""Janus kinase 3"", ""start_span"": 26, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""Janus kinase 3"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Protein""}, {""token"": ""STAT5a"", ""start_span"": 250, ""end_span"": 256, ""type"": ""Protein""}]"	valid
Exposure to LPS or TNF led to differential patterns of IkappaB - alpha and IkappaB - epsilon disappearance from and reassembly with the signalsome, whereas IKK - alpha, IKK - beta, and NIK remained complex - associated.	IkappaB - alpha,55,70,Protein	IkappaB - epsilon,75,92,Protein	IKK - alpha,156,167,Protein	IKK - beta,169,179,Protein	NIK,185,188,Protein	"[{""token"": ""IkappaB - alpha"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""IkappaB - epsilon"", ""start_span"": 75, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""IKK - alpha"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Protein""}, {""token"": ""IKK - beta"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Protein""}, {""token"": ""NIK"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Protein""}]"	valid
NIK cannot phosphorylate IkappaB - alpha directly, but it appears to be a functionally important subunit, because mutated NIK inhibited stimulus - induced kappaB - dependent transcription more effectively than mutated IKK - alpha or - beta.	NIK,0,3,Protein	IkappaB - alpha,25,40,Protein	NIK,122,125,Protein	IKK - alpha,218,229,Protein	- beta,233,239,Protein	"[{""token"": ""NIK"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 25, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""NIK"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""IKK - alpha"", ""start_span"": 218, ""end_span"": 229, ""type"": ""Protein""}, {""token"": ""- beta"", ""start_span"": 233, ""end_span"": 239, ""type"": ""Protein""}]"	valid
Here, we show that v - erbA and c - erbA bind directly to sequences within the promoter of the erythrocyte - specific carbonic anhydrase II ( CAII), a gene whose transcription is efficiently suppressed by v - erbA.	v - erbA,19,27,Protein	c - erbA,32,40,Protein	carbonic anhydrase II,118,139,Protein	CAII,142,146,Protein	v - erbA,205,213,Protein	"[{""token"": ""v - erbA"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""c - erbA"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""carbonic anhydrase II"", ""start_span"": 118, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""CAII"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""v - erbA"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Protein""}]"	valid
Triggering of the human interleukin - 6 gene by interferon - gamma and tumor necrosis factor - alpha in monocytic cells involves cooperation between interferon regulatory factor - 1, NF kappa B, and Sp1 transcription factors.	interleukin - 6,24,39,Protein	interferon - gamma,48,66,Protein	tumor necrosis factor - alpha,71,100,Protein	interferon regulatory factor - 1,149,181,Protein	Sp1,199,202,Protein	"[{""token"": ""interleukin - 6"", ""start_span"": 24, ""end_span"": 39, ""type"": ""Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 48, ""end_span"": 66, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 71, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""interferon regulatory factor - 1"", ""start_span"": 149, ""end_span"": 181, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Protein""}]"	valid
Our results indicate that not only the reported IL - 2 NF - AT and NFIL - 2A sites and Ig kappa B site, but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2 + mobilization.	IL - 2,48,54,Protein	NF - AT,55,62,Protein	NFIL - 2A,67,76,Protein	Ig kappa B,87,97,Protein	IL - 8,117,123,Protein	"[{""token"": ""IL - 2"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""NF - AT"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""NFIL - 2A"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""Ig kappa B"", ""start_span"": 87, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Protein""}]"	valid
Adhesion of human monocytes to P - selectin, the most rapidly expressed endothelial tethering factor, increased the secretion of monocyte chemotactic protein - 1 ( MCP - 1) and tumor necrosis factor - alpha ( TNF - alpha) by the leukocytes when they were stimulated with platelet - activating factor.	P - selectin,31,43,Protein	monocyte chemotactic protein - 1,129,161,Protein	MCP - 1,164,171,Protein	tumor necrosis factor - alpha,177,206,Protein	TNF - alpha,209,220,Protein	"[{""token"": ""P - selectin"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""monocyte chemotactic protein - 1"", ""start_span"": 129, ""end_span"": 161, ""type"": ""Protein""}, {""token"": ""MCP - 1"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 177, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Protein""}]"	valid
Murine macrophage inflammatory protein 1 alpha ( MIP - 1 alpha) and its human equivalent ( GOS19, LD78, or AT464) are members of the - C - C family of low - molecular - weight chemokines.	macrophage inflammatory protein 1 alpha,7,46,Protein	MIP - 1 alpha,49,62,Protein	GOS19,91,96,Protein	LD78,98,102,Protein	AT464,107,112,Protein	"[{""token"": ""macrophage inflammatory protein 1 alpha"", ""start_span"": 7, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""MIP - 1 alpha"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""GOS19"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""LD78"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""AT464"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Protein""}]"	valid
Transient transfection assays with EGR - 1 promoter fragments linked to the chloramphenicol acetyltransferase ( CAT) gene demonstrated that PWM induced EGR - 1 transcription is conferred by the CArG motif ( C C [ AT] 6GG) in the EGR - 1 promoter.	EGR - 1,35,42,Protein	chloramphenicol acetyltransferase,76,109,Protein	CAT,112,115,Protein	EGR - 1,152,159,Protein	EGR - 1,229,236,Protein	"[{""token"": ""EGR - 1"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 76, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""CAT"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""EGR - 1"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Protein""}, {""token"": ""EGR - 1"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Protein""}]"	valid
After stimulation, two new kappa B - specific complexes were identified as NF - kappa B p50 - p65 heterodimer and putative c - Rel homodimer or c - Rel - p65 heterodimer.	p50,88,91,Protein	p65,94,97,Protein	c - Rel,123,130,Protein	c - Rel,144,151,Protein	p65,154,157,Protein	"[{""token"": ""p50"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Protein""}]"	valid
RelA ( p65) functions as the critical transactivating component of the heterodimeric p50 - p65 NF - kappa B complex and contains a high - affinity binding site for its cytoplasmic inhibitor, I kappa B alpha.	RelA,0,4,Protein	p65,7,10,Protein	p50,85,88,Protein	p65,91,94,Protein	I kappa B alpha,191,206,Protein	"[{""token"": ""RelA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 191, ""end_span"": 206, ""type"": ""Protein""}]"	valid
The ability of Jun proteins to cooperate with GR in T cells has been investigated after transfection of c - jun, jun - B, or jun - D expression vectors, which augmented GR - dependent transcription from either MMTV LTR or GRE.	GR,46,48,Protein	c - jun,104,111,Protein	jun - B,113,120,Protein	jun - D,125,132,Protein	GR,169,171,Protein	"[{""token"": ""GR"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""c - jun"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""jun - B"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Protein""}, {""token"": ""jun - D"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""GR"", ""start_span"": 169, ""end_span"": 171, ""type"": ""Protein""}]"	valid
Costimulation of cells with LPS plus GM - CSF induced the production of proinflammatory cytokines, IL - 8, IL - 1 beta and IL - 6, but not TNF - alpha.	GM - CSF,37,45,Protein	IL - 8,99,105,Protein	IL - 1 beta,107,118,Protein	IL - 6,123,129,Protein	TNF - alpha,139,150,Protein	"[{""token"": ""GM - CSF"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Protein""}]"	valid
The expression of cell surface markers including the interleukin 2 receptor alpha ( IL - 2R alpha) chain ( CD25), CD69 and L - selectin ( CD62) is normal in mitogen - activated Rel - / - T cells, but cytokine production is impaired.	CD25,107,111,Protein	CD69,114,118,Protein	L - selectin,123,135,Protein	CD62,138,142,Protein	Rel,177,180,Protein	"[{""token"": ""CD25"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""CD69"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""L - selectin"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""CD62"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Protein""}, {""token"": ""Rel"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Protein""}]"	valid
Interestingly, the processing rate of p105 is markedly inhibited in cells co - transfected with p50 or other NF - kappaB subunits, including RelA and c - Rel, that physically interact with p105.	p105,38,42,Protein	p50,96,99,Protein	RelA,141,145,Protein	c - Rel,150,157,Protein	p105,189,193,Protein	"[{""token"": ""p105"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Protein""}]"	valid
Cotransfection of CMV IE genes and IL - 6 chloramphenicol acetyl transferase ( CAT) or IL - 6 luciferase constructs were used to study IL - 6 promoter activity.	IL - 6,35,41,Protein	chloramphenicol acetyl transferase,42,76,Protein	CAT,79,82,Protein	IL - 6,87,93,Protein	IL - 6,135,141,Protein	"[{""token"": ""IL - 6"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""chloramphenicol acetyl transferase"", ""start_span"": 42, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""CAT"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Protein""}]"	valid
We show that ligand - induced homodimerization of chimeric surface receptors consisting of the extracellular and transmembrane domains of the erythropoietin receptor and of the intracellular domain of IL - 4Ralpha induces Janus kinase 1 ( Jak1) activation, STAT6 activation, and Cepsilon germline transcripts in human B cell line BJAB.	erythropoietin,142,156,Protein	IL - 4Ralpha,201,213,Protein	Janus kinase 1,222,236,Protein	Jak1,239,243,Protein	STAT6,257,262,Protein	"[{""token"": ""erythropoietin"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""IL - 4Ralpha"", ""start_span"": 201, ""end_span"": 213, ""type"": ""Protein""}, {""token"": ""Janus kinase 1"", ""start_span"": 222, ""end_span"": 236, ""type"": ""Protein""}, {""token"": ""Jak1"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Protein""}, {""token"": ""STAT6"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Protein""}]"	valid
During CD30 signal transduction, we found that binding of TRAF2 to the cytoplasmic domain of CD30 results in the rapid depletion of TRAF2 and the associated protein TRAF1 by proteolysis.	CD30,7,11,Protein	TRAF2,58,63,Protein	CD30,93,97,Protein	TRAF2,132,137,Protein	TRAF1,165,170,Protein	"[{""token"": ""CD30"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""CD30"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""TRAF1"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Protein""}]"	valid
TRADD associated with wild - type LMP1 but not with isoleucine - mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV - transformed cells.	TRADD,0,5,Protein	LMP1,34,38,Protein	LMP1,73,77,Protein	TRADD,102,107,Protein	LMP1,139,143,Protein	"[{""token"": ""TRADD"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""TRADD"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Protein""}]"	valid
Engagement of any of these receptors induces the rapid tyrosine phosphorylation of a shared group of intracellular signaling proteins, including Vav, Cbl, p85 phosphoinositide 3 - kinase, and the Src family kinases Lck and Fyn.	Vav,145,148,Protein	Cbl,150,153,Protein	Src,196,199,Protein	Lck,215,218,Protein	Fyn,223,226,Protein	"[{""token"": ""Vav"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Protein""}, {""token"": ""Cbl"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""Src"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Protein""}, {""token"": ""Lck"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Protein""}, {""token"": ""Fyn"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Protein""}]"	valid
Unlike ligation of CD3, stimulation with anti - CD28 mAb or CHO cells expressing the CD28 ligands CD80 or CD86 did not lead to tyrosine phosphorylation of HS1 in Jurkat T cells.	CD28,48,52,Protein	CD28,85,89,Protein	CD80,98,102,Protein	CD86,106,110,Protein	HS1,155,158,Protein	"[{""token"": ""CD28"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""CD80"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""CD86"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""HS1"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Protein""}]"	valid
In vivo studies indicated that CD3 - induced HSI phosphorylation was dependent upon both the Src family tyrosine kinase Lck and the tyrosine phosphatase CD45, did not require MEK1 kinase activity, and was regulated by protein kinase C activation.	HSI,45,48,Protein	Src,93,96,Protein	Lck,120,123,Protein	CD45,153,157,Protein	MEK1,175,179,Protein	"[{""token"": ""HSI"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""Src"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""Lck"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""CD45"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""MEK1"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Protein""}]"	valid
Previous studies have shown constitutive activation of IL - 4 and IL - 7 signaling pathways, as measured by activation of Janus protein kinase ( JAK) 1, JAK3, STAT5, and STAT6, in pre - B cells transformed by v - Abl.	IL - 4,55,61,Protein	IL - 7,66,72,Protein	JAK3,153,157,Protein	STAT6,170,175,Protein	v - Abl,209,216,Protein	"[{""token"": ""IL - 4"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""IL - 7"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""JAK3"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""STAT6"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Protein""}, {""token"": ""v - Abl"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Protein""}]"	valid
These results identify a potential role for IL - 7 signaling pathways in transformation by v - Abl while demonstrating that a combination of IL - 4 and IL - 7 signaling cannot substitute for an active v - Abl kinase in transformed pre - B cells.	IL - 7,44,50,Protein	v - Abl,91,98,Protein	IL - 4,141,147,Protein	IL - 7,152,158,Protein	v - Abl,201,208,Protein	"[{""token"": ""IL - 7"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Protein""}, {""token"": ""v - Abl"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""IL - 7"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Protein""}, {""token"": ""v - Abl"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Protein""}]"	valid
In contrast, p21ras signals are unable to induce Akt / PKB activity in T cell nor is Ras function required for Akt / PKB activation in response to the TCR.	p21ras,13,19,Protein	Akt,49,52,Protein	PKB,55,58,Protein	Akt,111,114,Protein	PKB,117,120,Protein	"[{""token"": ""p21ras"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Protein""}, {""token"": ""Akt"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Protein""}, {""token"": ""PKB"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""Akt"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""PKB"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Protein""}]"	valid
We demonstrate here the interaction of RANK with tumor necrosis factor receptor - associated factors ( TRAFs) 1, 2, 3, 5, and 6 both in vitro and in cells.	RANK,39,43,Protein	2,113,114,Protein	3,116,117,Protein	5,119,120,Protein	6,126,127,Protein	"[{""token"": ""RANK"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 113, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 116, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""5"", ""start_span"": 119, ""end_span"": 120, ""type"": ""Protein""}, {""token"": ""6"", ""start_span"": 126, ""end_span"": 127, ""type"": ""Protein""}]"	valid
In particular, TRAF6 interacted with membrane - proximal determinants distinct from those binding TRAFs 1, 2, 3, and 5.	TRAF6,15,20,Protein	TRAFs 1,98,105,Protein	2,107,108,Protein	3,110,111,Protein	5,117,118,Protein	"[{""token"": ""TRAF6"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Protein""}, {""token"": ""TRAFs 1"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 107, ""end_span"": 108, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 110, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""5"", ""start_span"": 117, ""end_span"": 118, ""type"": ""Protein""}]"	valid
Interestingly, Nmi lacks an intrinsic transcriptional activation domain; instead, Nmi enhances the association of CBP / p300 coactivator proteins with Stat1 and Stat5, and together with CBP / p300 can augment IL - 2 - and IFNgamma - dependent transcription.	Nmi,15,18,Protein	Nmi,82,85,Protein	Stat1,151,156,Protein	IL - 2,209,215,Protein	IFNgamma,222,230,Protein	"[{""token"": ""Nmi"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""Nmi"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""Stat1"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Protein""}]"	valid
Binding of interferon - gamma ( IFN - gamma) to its heterodimeric receptor induces activation of the tyrosine kinases JAK1 and JAK2 followed by tyrosine phosphorylation of STAT1alpha.	interferon - gamma,11,29,Protein	IFN - gamma,32,43,Protein	JAK1,118,122,Protein	JAK2,127,131,Protein	STAT1alpha,172,182,Protein	"[{""token"": ""interferon - gamma"", ""start_span"": 11, ""end_span"": 29, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""JAK1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""JAK2"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""STAT1alpha"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Protein""}]"	test
In this report, we have analyzed the response of the hematopoietic precursor cell line 32Dcl3, expressing either the normal protein MDS1 / EVI1 or the fusion protein AML1 / MDS1 / EVI1, to factors that control cell differentiation or cell replication.	MDS1,132,136,Protein	EVI1,139,143,Protein	AML1,166,170,Protein	MDS1,173,177,Protein	EVI1,180,184,Protein	"[{""token"": ""MDS1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Protein""}, {""token"": ""AML1"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Protein""}, {""token"": ""MDS1"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Protein""}]"	test
1, 25 - Dihydroxyvitamin D3 induces differentiation of a retinoic acid - resistant acute promyelocytic leukemia cell line ( UF - 1) associated with expression of p21 ( WAF1 / CIP1) and p27 ( KIP1).	p21,162,165,Protein	WAF1,168,172,Protein	CIP1,175,179,Protein	p27,185,188,Protein	KIP1,191,195,Protein	"[{""token"": ""p21"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Protein""}, {""token"": ""WAF1"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Protein""}, {""token"": ""CIP1"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Protein""}, {""token"": ""p27"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Protein""}, {""token"": ""KIP1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Protein""}]"	test
Associated with these findings, the levels of p21 ( WAF1 / CIP1) and p27 ( KIP1) mRNA and protein increased in these cells.	p21,46,49,Protein	WAF1,52,56,Protein	CIP1,59,63,Protein	p27,69,72,Protein	KIP1,75,79,Protein	"[{""token"": ""p21"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""WAF1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""CIP1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""p27"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""KIP1"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Protein""}]"	test
Northern blot analysis showed that p21 ( WAF1 / CIP1) and p27 ( KIP1) mRNA and protein increased in these cells.	p21,35,38,Protein	WAF1,41,45,Protein	CIP1,48,52,Protein	p27,58,61,Protein	KIP1,64,68,Protein	"[{""token"": ""p21"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""WAF1"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""CIP1"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Protein""}, {""token"": ""p27"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""KIP1"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Protein""}]"	test
Northern blot analysis showed that p21 ( WAF1 / CIP1) and p27 ( KIP1) transcripts were induced after 6 hours ' exposure to 1, 25 ( OH) 2D3 and then decreased to basal levels over 48 hours.	p21,35,38,Protein	WAF1,41,45,Protein	CIP1,48,52,Protein	p27,58,61,Protein	KIP1,64,68,Protein	"[{""token"": ""p21"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""WAF1"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""CIP1"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Protein""}, {""token"": ""p27"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""KIP1"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Protein""}]"	test
Western blot experiments showed that p21 ( WAF1 / CIP1) protein levels increased and became detectable after 12 hours of 1, 25 ( OH) 2D3 treatment and induction of p27 ( KIP1) protein was much more gradual and sustained in UF - 1 cells.	p21,37,40,Protein	WAF1,43,47,Protein	CIP1,50,54,Protein	p27,164,167,Protein	KIP1,170,174,Protein	"[{""token"": ""p21"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""WAF1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""CIP1"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""p27"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Protein""}, {""token"": ""KIP1"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Protein""}]"	test
In contrast, RA alone can induce G1 arrest of UF - 1 cells; however, it did not result in an increase of p21 ( WAF1 / CIP1) and p27 ( KIP1) transcript and protein expression in RA - resistant cells.	p21,105,108,Protein	WAF1,111,115,Protein	CIP1,118,122,Protein	p27,128,131,Protein	KIP1,134,138,Protein	"[{""token"": ""p21"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Protein""}, {""token"": ""WAF1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""CIP1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""p27"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""KIP1"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Protein""}]"	test
Jak1, Jak3, Stat1, Stat3, and Stat5 expression is suppressed approximately to, or below the level of unstimulated cells.	Jak1,0,4,Protein	Jak3,6,10,Protein	Stat1,12,17,Protein	Stat3,19,24,Protein	Stat5,30,35,Protein	"[{""token"": ""Jak1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Protein""}, {""token"": ""Jak3"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""Stat1"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Protein""}, {""token"": ""Stat3"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""Stat5"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Protein""}]"	test
In - vitro cleavage of recombinant SP1 by recombinant caspase 3 ( CPP32) or caspase 7 ( Mch 3) results in similar cleavage products as those observed in vivo.	SP1,35,38,Protein	caspase 3,54,63,Protein	CPP32,66,71,Protein	caspase 7,76,85,Protein	Mch 3,88,93,Protein	"[{""token"": ""SP1"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""caspase 3"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""CPP32"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""caspase 7"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""Mch 3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Protein""}]"	test
Double staining for Bcl - 6 / CD20, Bcl - 6 / CD3, and Bcl - 6 / CD57 was performed in selected cases.	Bcl - 6,20,27,Protein	CD20,30,34,Protein	Bcl - 6,36,43,Protein	Bcl - 6,55,62,Protein	CD57,65,69,Protein	"[{""token"": ""Bcl - 6"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""CD20"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""Bcl - 6"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""Bcl - 6"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""CD57"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Protein""}]"	test
Here we demonstrate that both Smad6 and Smad7 are human bone morphogenetic protein - 2 ( hBMP - 2) - inducible antagonists of hBMP - 2 - induced growth arrest and apoptosis in mouse B cell hybridoma HS - 72 cells.	Smad6,30,35,Protein	Smad7,40,45,Protein	human bone morphogenetic protein - 2,50,86,Protein	hBMP - 2,89,97,Protein	hBMP - 2,126,134,Protein	"[{""token"": ""Smad6"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""Smad7"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""human bone morphogenetic protein - 2"", ""start_span"": 50, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""hBMP - 2"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""hBMP - 2"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Protein""}]"	test
Moreover, we confirmed that the ectopic expressions of Smad6 and Smad7 inhibited the hBMP - 2 - induced Smad1 / Smad5 phosphorylation.	Smad6,55,60,Protein	Smad7,65,70,Protein	hBMP - 2,85,93,Protein	Smad1,104,109,Protein	Smad5,112,117,Protein	"[{""token"": ""Smad6"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""Smad7"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""hBMP - 2"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""Smad1"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""Smad5"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Protein""}]"	test
This effect can be associated with the activation of specific hormone receptors, since we observed the expression of the estrogen receptor alpha ( ER - alpha), ER - beta, and progesterone receptor ( PR) mRNAs; the ER - alpha protein expression was confirmed by immunocytochemical analysis.	ER - alpha,147,157,Protein	ER - beta,160,169,Protein	progesterone receptor,175,196,Protein	PR,199,201,Protein	ER - alpha,214,224,Protein	"[{""token"": ""ER - alpha"", ""start_span"": 147, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""ER - beta"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Protein""}, {""token"": ""progesterone receptor"", ""start_span"": 175, ""end_span"": 196, ""type"": ""Protein""}, {""token"": ""PR"", ""start_span"": 199, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""ER - alpha"", ""start_span"": 214, ""end_span"": 224, ""type"": ""Protein""}]"	test
Furthermore, epithelial levels of activated Stat1 correlated with levels of expression for epithelial ICAM - 1, IRF - 1, and Stat1, and in turn, ICAM - 1 levels correlated with T - cell accumulation in tissue.	Stat1,44,49,Protein	ICAM - 1,102,110,Protein	IRF - 1,112,119,Protein	Stat1,125,130,Protein	ICAM - 1,145,153,Protein	"[{""token"": ""Stat1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""IRF - 1"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""Stat1"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Protein""}]"	test
A cdk2 inhibitor, Olomoucine, as well as a dominant - negative cdk2 construct prevented HLA class I - mediated inactivation of Rb; in contrast, dominant - negative cdk4 and cdk6 constructs had no effect.	cdk2,2,6,Protein	cdk2,63,67,Protein	Rb,127,129,Protein	cdk4,164,168,Protein	cdk6,173,177,Protein	"[{""token"": ""cdk2"", ""start_span"": 2, ""end_span"": 6, ""type"": ""Protein""}, {""token"": ""cdk2"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""Rb"", ""start_span"": 127, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""cdk4"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Protein""}, {""token"": ""cdk6"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Protein""}]"	test
Upon HBsAg stimulation, expression of IFN - gamma, IL - 2, IL - 4, and IL - 10 was detected in 41%, 8%, 41%, and 50% of the patients, respectively.	HBsAg,5,10,Protein	IFN - gamma,38,49,Protein	IL - 2,51,57,Protein	IL - 4,59,65,Protein	IL - 10,71,78,Protein	"[{""token"": ""HBsAg"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Protein""}]"	test
Constitutive activations of PKB / Akt, STAT5a, and STAT5b were noted in these EPO - independent cells.	PKB,28,31,Protein	Akt,34,37,Protein	STAT5a,39,45,Protein	STAT5b,51,57,Protein	EPO,78,81,Protein	"[{""token"": ""PKB"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""Akt"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""STAT5a"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""STAT5b"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""EPO"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Protein""}]"	test
The interaction of LMP1 and JAK3 leads to the enhanced tyrosine auto / transphosphorylation of JAK3 within minutes after crosslinking of a conditional NGF - R: LMP1 chimera and is a prerequisite for the activation of STAT transcription factors.	LMP1,19,23,Protein	JAK3,28,32,Protein	JAK3,95,99,Protein	NGF - R,151,158,Protein	LMP1,160,164,Protein	"[{""token"": ""LMP1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Protein""}, {""token"": ""JAK3"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Protein""}, {""token"": ""JAK3"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""NGF - R"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Protein""}]"	test
Constitutive active versions of c - Raf and Rac synergistically enhance the CBP / p300 - mediated increase of TAD - A activity, indicating the important role CBP / p300 plays in the integration of T cell activation signals.	c - Raf,32,39,Protein	CBP,76,79,Protein	p300,82,86,Protein	CBP,158,161,Protein	p300,164,168,Protein	"[{""token"": ""c - Raf"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Protein""}, {""token"": ""CBP"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""p300"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""CBP"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Protein""}, {""token"": ""p300"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Protein""}]"	test
However, activation of STAT6, CD23 expression, and IgE synthesis induced by IL - 4 were not affected in p47phox - deficient patients, which raises the possibility that p47phox may be important in other signaling activities as well in B cells.	STAT6,23,28,Protein	CD23,30,34,Protein	IL - 4,76,82,Protein	p47phox,104,111,Protein	p47phox,168,175,Protein	"[{""token"": ""STAT6"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""CD23"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""p47phox"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""p47phox"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Protein""}]"	test
Mutation of Aiolos - binding sites within the Bcl - 2 promoter inhibits transactivation of the reporter gene luciferase, suggesting direct control of Bcl - 2 expression by Aiolos.	Aiolos,12,18,Protein	Bcl - 2,46,53,Protein	luciferase,109,119,Protein	Bcl - 2,150,157,Protein	Aiolos,172,178,Protein	"[{""token"": ""Aiolos"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""luciferase"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""Aiolos"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Protein""}]"	test
In these experiments, SOCS - 3 associated with Jak1 and inhibited Jak1 phosphorylation, and this inhibition was markedly enhanced by the presence of IL - 2 receptor beta chain ( IL - 2Rbeta).	SOCS - 3,22,30,Protein	Jak1,47,51,Protein	Jak1,66,70,Protein	IL - 2 receptor beta chain,149,175,Protein	IL - 2Rbeta,178,189,Protein	"[{""token"": ""SOCS - 3"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Protein""}, {""token"": ""Jak1"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""Jak1"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""IL - 2 receptor beta chain"", ""start_span"": 149, ""end_span"": 175, ""type"": ""Protein""}, {""token"": ""IL - 2Rbeta"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Protein""}]"	test
Moreover, following IL - 2 stimulation of T cells, SOCS - 3 was able to interact with the IL - 2 receptor complex, and in particular tyrosine phosphorylated Jak1 and IL - 2Rbeta.	IL - 2,20,26,Protein	SOCS - 3,51,59,Protein	IL - 2,90,96,Protein	Jak1,157,161,Protein	IL - 2Rbeta,166,177,Protein	"[{""token"": ""IL - 2"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""SOCS - 3"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""Jak1"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Protein""}, {""token"": ""IL - 2Rbeta"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Protein""}]"	test
Here we provide novel evidence that AG - 490 potently inhibits the autokinase activity of JAK3 and tyrosine phosphorylation and DNA binding of signal transducer and activator of transcription 5a and 5b ( STAT5a / b).	JAK3,90,94,Protein	signal transducer and activator of transcription 5a,143,194,Protein	5b,199,201,Protein	STAT5a,204,210,Protein	b,213,214,Protein	"[{""token"": ""JAK3"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""signal transducer and activator of transcription 5a"", ""start_span"": 143, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""5b"", ""start_span"": 199, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""STAT5a"", ""start_span"": 204, ""end_span"": 210, ""type"": ""Protein""}, {""token"": ""b"", ""start_span"": 213, ""end_span"": 214, ""type"": ""Protein""}]"	test
Here we demonstrate, with a site - specific antibody, that STAT3 is phosphorylated on Ser - 727 in human neutrophils stimulated with chemotactic factors ( N - formyl - methionyl - leucyl - phenylalanine and complement C5a), cytokines [ granulocyte / macrophage colony - stimulating factor ( GM - CSF) and granulocyte colony - stimulating factor ( G - CSF)], or a protein kinase C activator ( PMA).	STAT3,59,64,Protein	granulocyte / macrophage colony - stimulating factor,236,288,Protein	GM - CSF,291,299,Protein	granulocyte colony - stimulating factor,305,344,Protein	G - CSF,347,354,Protein	"[{""token"": ""STAT3"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""granulocyte / macrophage colony - stimulating factor"", ""start_span"": 236, ""end_span"": 288, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 291, ""end_span"": 299, ""type"": ""Protein""}, {""token"": ""granulocyte colony - stimulating factor"", ""start_span"": 305, ""end_span"": 344, ""type"": ""Protein""}, {""token"": ""G - CSF"", ""start_span"": 347, ""end_span"": 354, ""type"": ""Protein""}]"	test
Analysis of cell lines Daudi and THP - 1 that differentially express gamma ( c) and IL - 13R alpha1 showed that IL - 13 can activate STAT6 in IL - 13R alpha1 - positive THP - 1 cells but not in gamma ( c) - positive, IL - 13R alpha1 - negative Daudi cells.	IL - 13R alpha1,84,99,Protein	IL - 13,112,119,Protein	STAT6,133,138,Protein	IL - 13R alpha1,142,157,Protein	IL - 13R alpha1,217,232,Protein	"[{""token"": ""IL - 13R alpha1"", ""start_span"": 84, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""IL - 13"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""STAT6"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""IL - 13R alpha1"", ""start_span"": 142, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""IL - 13R alpha1"", ""start_span"": 217, ""end_span"": 232, ""type"": ""Protein""}]"	test
Taken together, these results suggest that IL - 10 - activated STAT1 has a specificity in binding to the GAS - motif sequences, whereas IFN - gamma - activated STAT1 and STAT5 have a broader spectrum in binding to the GAS - motif sequences.	IL - 10,43,50,Protein	STAT1,63,68,Protein	IFN - gamma,136,147,Protein	STAT1,160,165,Protein	STAT5,170,175,Protein	"[{""token"": ""IL - 10"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Protein""}, {""token"": ""STAT5"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Protein""}]"	test
Compared with IL - 2, CD3 ligation induces a delayed Stat3 binding to oligonucleotide probes from the ICAM - 1 and IL - 2R alpha promoter.	IL - 2,14,20,Protein	CD3,22,25,Protein	Stat3,53,58,Protein	ICAM - 1,102,110,Protein	IL - 2R alpha,115,128,Protein	"[{""token"": ""IL - 2"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""Stat3"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Protein""}]"	test
The v - erbA oncogene, a mutated version of the thyroid hormone receptor alpha ( c - erbA / TR - alpha), inhibits erythroid differentiation and constitutively represses transcription of certain erythrocyte genes, suggesting a normal function of the proto - oncogene c - erbA in erythropoiesis.	v - erbA,4,12,Protein	thyroid hormone receptor alpha,48,78,Protein	c - erbA,81,89,Protein	TR - alpha,92,102,Protein	c - erbA,266,274,Protein	"[{""token"": ""v - erbA"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""thyroid hormone receptor alpha"", ""start_span"": 48, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""c - erbA"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""TR - alpha"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""c - erbA"", ""start_span"": 266, ""end_span"": 274, ""type"": ""Protein""}]"	test
Here we demonstrate that the endogenous thyroid hormone receptor alpha ( c - erbA / TR - alpha) and the closely related retinoic acid receptor alpha ( RAR - alpha) play a role in the regulation of normal erythroid differentiation.	thyroid hormone receptor alpha,40,70,Protein	c - erbA,73,81,Protein	TR - alpha,84,94,Protein	retinoic acid receptor alpha,120,148,Protein	RAR - alpha,151,162,Protein	"[{""token"": ""thyroid hormone receptor alpha"", ""start_span"": 40, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""c - erbA"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""TR - alpha"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""retinoic acid receptor alpha"", ""start_span"": 120, ""end_span"": 148, ""type"": ""Protein""}, {""token"": ""RAR - alpha"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Protein""}]"	test
OCA - B stimulates the transcription from an IgH promoter in conjunction with either Oct - 1 or Oct - 2 but shows no significant effect on the octamer / Oct - dependent transcription of the ubiquitously expressed histone H2B promoter and the transcription of USF - and Sp1 - regulated promoters.	OCA - B,0,7,Protein	Oct - 1,85,92,Protein	Oct - 2,96,103,Protein	USF,259,262,Protein	Sp1,269,272,Protein	"[{""token"": ""OCA - B"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""Oct - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""Oct - 2"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""USF"", ""start_span"": 259, ""end_span"": 262, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 269, ""end_span"": 272, ""type"": ""Protein""}]"	test
The expression of c - fos, c - jun and jun B proto - oncogenes was studied in phytohemagglutinin ( PHA) activated peripheral blood lymphocytes ( PBL) from young and aged humans.	c - fos,18,25,Protein	c - jun,27,34,Protein	jun B,39,44,Protein	phytohemagglutinin,78,96,Protein	PHA,99,102,Protein	"[{""token"": ""c - fos"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""c - jun"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""jun B"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""phytohemagglutinin"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""PHA"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Protein""}]"	test
These results suggest that the decreased IL - 2 production and proliferative response displayed by PHA - activated PBL from elderly adults may be related to age - related changes in c - jun mRNA expression and in the ratio of c - fos to c - jun mRNA.	IL - 2,41,47,Protein	PHA,99,102,Protein	c - jun,182,189,Protein	c - fos,226,233,Protein	c - jun,237,244,Protein	"[{""token"": ""IL - 2"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""PHA"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""c - jun"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Protein""}, {""token"": ""c - fos"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Protein""}, {""token"": ""c - jun"", ""start_span"": 237, ""end_span"": 244, ""type"": ""Protein""}]"	test
Although anti - CD3 alone or fibronectin alone cannot induce IL - 2 message by CD4 cells, the combination of anti - CD3 plus fibronectin induced IL - 2 message by CD4 cells.	fibronectin,29,40,Protein	IL - 2,61,67,Protein	CD4,79,82,Protein	fibronectin,125,136,Protein	IL - 2,145,151,Protein	"[{""token"": ""fibronectin"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""fibronectin"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Protein""}]"	test
Consistent with this result, these cell lines expressed increased levels of mRNAs encoding the AP - 1 proteins, c - Fos, Fra - 1, c - Jun, JunB, and JunD.	c - Fos,112,119,Protein	Fra - 1,121,128,Protein	c - Jun,130,137,Protein	JunB,139,143,Protein	JunD,149,153,Protein	"[{""token"": ""c - Fos"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""Fra - 1"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""c - Jun"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""JunB"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Protein""}, {""token"": ""JunD"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Protein""}]"	test
By using the human T - cell line ( JPX - 9), in which expression of the Tax1 is inducible, we showed that expression of mRNAs for Fra - 1, c - Jun, and JunD was also transactivated by Tax1.	Tax1,72,76,Protein	Fra - 1,130,137,Protein	c - Jun,139,146,Protein	JunD,152,156,Protein	Tax1,184,188,Protein	"[{""token"": ""Tax1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""Fra - 1"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""c - Jun"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""JunD"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""Tax1"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Protein""}]"	test
( iv) No other EBV genes were required for EBNA - 2 transactivation of LMP1 since cotransfection of recombinant EBNA - 2 expression vectors and genomic LMP1 DNA fragments enhanced LMP1 expression in the EBV - negative B - lymphoma cell lines BJAB, Louckes, and BL30.	EBNA - 2,43,51,Protein	LMP1,71,75,Protein	EBNA - 2,112,120,Protein	LMP1,152,156,Protein	LMP1,180,184,Protein	"[{""token"": ""EBNA - 2"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""EBNA - 2"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Protein""}]"	test
The rex gene encodes two protein products, p27rex / p21rex and p26rex / p24rex in HTLV - I and HTLV - II, respectively.	rex,4,7,Protein	p27rex,43,49,Protein	p21rex,52,58,Protein	p26rex,63,69,Protein	p24rex,72,78,Protein	"[{""token"": ""rex"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""p27rex"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""p21rex"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""p26rex"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Protein""}, {""token"": ""p24rex"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Protein""}]"	test
We have identified a novel cellular protein, Bik, that interacts with the cellular survival - promoting proteins, Bcl - 2 and Bcl - xL, as well as the viral survival - promoting proteins, Epstein Barr virus - BHRF1 and adenovirus E1B - 19 kDa.	Bik,45,48,Protein	Bcl - 2,114,121,Protein	Bcl - xL,126,134,Protein	BHRF1,209,214,Protein	E1B - 19 kDa,230,242,Protein	"[{""token"": ""Bik"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""BHRF1"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Protein""}, {""token"": ""E1B - 19 kDa"", ""start_span"": 230, ""end_span"": 242, ""type"": ""Protein""}]"	test
This death - promoting activity of Bik can be suppressed by coexpression of Bcl - 2, Bcl - XL, EBV - BHRF1 and E1B - 19 kDa proteins suggesting that Bik may be a common target for both cellular and viral anti - apoptotic proteins.	Bik,35,38,Protein	Bcl - 2,76,83,Protein	Bcl - XL,85,93,Protein	EBV - BHRF1,95,106,Protein	Bik,149,152,Protein	"[{""token"": ""Bik"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""Bcl - XL"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""EBV - BHRF1"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""Bik"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Protein""}]"	test
Thus, after 4 hr of exposure to SEA and SEB, the expression of IL - 2R beta was down - regulated, IL - 2R gamma was slightly up - regulated, while IL - 2R alpha remained largely unaffected.	SEA,32,35,Protein	SEB,40,43,Protein	IL - 2R beta,63,75,Protein	IL - 2R gamma,98,111,Protein	IL - 2R alpha,147,160,Protein	"[{""token"": ""SEA"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""SEB"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 98, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Protein""}]"	test
The changes in the composition of IL - 2Rs were accompanied by inhibition of IL - 2 - induced tyrosine phosphorylation of the Janus protein - tyrosine kinase 3 ( Jak3) and signal transducers and activators of transcription called Stat3 and Stat5.	IL - 2,34,40,Protein	Janus protein - tyrosine kinase 3,126,159,Protein	Jak3,162,166,Protein	Stat3,230,235,Protein	Stat5,240,245,Protein	"[{""token"": ""IL - 2"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""Janus protein - tyrosine kinase 3"", ""start_span"": 126, ""end_span"": 159, ""type"": ""Protein""}, {""token"": ""Jak3"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Protein""}, {""token"": ""Stat3"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Protein""}, {""token"": ""Stat5"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Protein""}]"	test
Moreover, the induction of both Jak 1 and 3, and STAT 5 activity strongly correlated with the growth - promoting effects of IL - 7, suggesting that this signal transduction mechanism may play a key role in IL - 7 - induced proliferation.	Jak 1,32,37,Protein	3,42,43,Protein	STAT 5,49,55,Protein	IL - 7,124,130,Protein	IL - 7,206,212,Protein	"[{""token"": ""Jak 1"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 42, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""STAT 5"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""IL - 7"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""IL - 7"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Protein""}]"	test
Multicolor flow cytometric assays confirmed the coexpression of myeloid ( CD33, CD13, CD15) and NK cell - associated ( CD56) antigens in each case, whereas reverse transcription polymerase chain reaction ( RT - PCR) assays confirmed the identity of CD56 ( neural cell adhesion molecule) in leukemic blasts.	CD33,74,78,Protein	CD13,80,84,Protein	CD15,86,90,Protein	CD56,119,123,Protein	CD56,249,253,Protein	"[{""token"": ""CD33"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""CD13"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Protein""}, {""token"": ""CD15"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""CD56"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""CD56"", ""start_span"": 249, ""end_span"": 253, ""type"": ""Protein""}]"	test
Four of 6 cases tested showed functional NK cell - mediated cytotoxicity, suggesting a relationship between these unique CD33 +, CD56 +, CD16 - acute leukemias and normal CD56 +, CD16 - NK precursor cells.	CD33,121,125,Protein	CD56,129,133,Protein	CD16,137,141,Protein	CD56,171,175,Protein	CD16,179,183,Protein	"[{""token"": ""CD33"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""CD56"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""CD16"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""CD56"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Protein""}, {""token"": ""CD16"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Protein""}]"	test
Transactivation of the ICAM - I promoter by TaxI was further shown by co - transfection of a CAT reporter construct with the ICAM - I promoter and a plasmid expressing TaxI.	ICAM - I,23,31,Protein	TaxI,44,48,Protein	CAT,93,96,Protein	ICAM - I,125,133,Protein	TaxI,168,172,Protein	"[{""token"": ""ICAM - I"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""TaxI"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""CAT"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""ICAM - I"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""TaxI"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Protein""}]"	test
In addition, the Ah receptor complex recognized a DNA binding site for B cell lineage - specific activator protein ( BSAP) in the promoter region of the human CD19 gene which is similar to the consensus Ah receptor DNA binding site.	Ah receptor,17,28,Protein	B cell lineage - specific activator protein,71,114,Protein	BSAP,117,121,Protein	CD19,159,163,Protein	Ah receptor,203,214,Protein	"[{""token"": ""Ah receptor"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""B cell lineage - specific activator protein"", ""start_span"": 71, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""BSAP"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""CD19"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""Ah receptor"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Protein""}]"	test
IL - 10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes.	IL - 10,0,7,Protein	tyk2,48,52,Protein	Jak1,57,61,Protein	STAT1 alpha,95,106,Protein	STAT3,111,116,Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""tyk2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Protein""}, {""token"": ""Jak1"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""STAT3"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Protein""}]"	test
IL - 10 treatment of both T cells and monocytes results in the ligand - induced tyrosine phosphorylation of tyk2 and Jak1, but not Jak2 or Jak3.	IL - 10,0,7,Protein	tyk2,108,112,Protein	Jak1,117,121,Protein	Jak2,131,135,Protein	Jak3,139,143,Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""tyk2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Protein""}, {""token"": ""Jak1"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""Jak2"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""Jak3"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Protein""}]"	test
Whereas the Jak kinases Jak1 and Jak3 and the signal transducer and activator of transcription proteins Stat3 and Stat5 are activated in normal T cells in response to IL - 2, this signaling pathway was constitutively activated in HTLV - I - transformed cells.	Jak1,24,28,Protein	Jak3,33,37,Protein	Stat3,104,109,Protein	Stat5,114,119,Protein	IL - 2,167,173,Protein	"[{""token"": ""Jak1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""Jak3"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""Stat3"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""Stat5"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Protein""}]"	test
RB and a novel E2F - 1 binding protein in MHC class II deficient B - cell lines and normal IFN - gamma induction of the class IL transactivator CIITA in class II non - inducible RB - defective tumor lines.	RB,0,2,Protein	E2F - 1,15,22,Protein	IFN - gamma,91,102,Protein	CIITA,144,149,Protein	RB,178,180,Protein	"[{""token"": ""RB"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Protein""}, {""token"": ""E2F - 1"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""CIITA"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Protein""}, {""token"": ""RB"", ""start_span"": 178, ""end_span"": 180, ""type"": ""Protein""}]"	test
CIITA mRNA is normally inducible by IFN - gamma in class II non - inducible, RB - defective lines, and in one line, re - expression of RB has no effect on CIITA mRNA induction levels.	CIITA,0,5,Protein	IFN - gamma,36,47,Protein	RB,77,79,Protein	RB,135,137,Protein	CIITA,155,160,Protein	"[{""token"": ""CIITA"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""RB"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""RB"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""CIITA"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Protein""}]"	test
The aberrant activation of AP - 1 by gp160 in CD4 positive T cells could result in up - regulation of cytokines containing AP - 1 sites, e. g. interleukin - 3 and granulocyte macrophage colony - stimulating factor, and concurrently lead to T cell unresponsiveness by inhibiting interleukin - 2 secretion.	gp160,37,42,Protein	CD4,46,49,Protein	interleukin - 3,143,158,Protein	granulocyte macrophage colony - stimulating factor,163,213,Protein	interleukin - 2,278,293,Protein	"[{""token"": ""gp160"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 143, ""end_span"": 158, ""type"": ""Protein""}, {""token"": ""granulocyte macrophage colony - stimulating factor"", ""start_span"": 163, ""end_span"": 213, ""type"": ""Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 278, ""end_span"": 293, ""type"": ""Protein""}]"	test
In addition, when used together IL - 2 and IL - 12 synergized in the induction of IFN - gamma and GM - CSF and this synergy was attributed to an increased accumulation and stability of the IFN - gamma and GM - CSF mRNAs.	IL - 2,32,38,Protein	IFN - gamma,82,93,Protein	GM - CSF,98,106,Protein	IFN - gamma,189,200,Protein	GM - CSF,205,213,Protein	"[{""token"": ""IL - 2"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 189, ""end_span"": 200, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Protein""}]"	test
With the recent characterization of the FY * A and FY * B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid - specific repression of the DARC gene in Duffy - negative individuals.	FY * A,40,46,Protein	FY * B,51,57,Protein	Duffy,117,122,Protein	DARC,208,212,Protein	Duffy,221,226,Protein	"[{""token"": ""FY * A"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""FY * B"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""Duffy"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""DARC"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Protein""}, {""token"": ""Duffy"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Protein""}]"	test
The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL - 2, IL - 4, IL - 7, IL - 13, and IL - 15.	IL - 2,119,125,Protein	IL - 4,127,133,Protein	IL - 7,135,141,Protein	IL - 13,143,150,Protein	IL - 15,156,163,Protein	"[{""token"": ""IL - 2"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""IL - 7"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""IL - 13"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Protein""}, {""token"": ""IL - 15"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Protein""}]"	test
Interleukin - 2 ( IL - 2) rapidly activated Stat5 in fresh PBL, and Stat3 and Stat5 in preactivated PBL.	Interleukin - 2,0,15,Protein	IL - 2,18,24,Protein	Stat5,44,49,Protein	Stat3,68,73,Protein	Stat5,78,83,Protein	"[{""token"": ""Interleukin - 2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""Stat5"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""Stat3"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""Stat5"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Protein""}]"	test
IL - 7 and IL - 15 induced the same complexes as IL - 2, a feature explained by the existence of similar tyrosine - phosphorylated motifs in the cytoplasmic domains of IL - 2R beta and IL - 7R that can serve as docking sites for Stat proteins.	IL - 7,0,6,Protein	IL - 15,11,18,Protein	IL - 2,49,55,Protein	IL - 2R beta,168,180,Protein	IL - 7R,185,192,Protein	"[{""token"": ""IL - 7"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Protein""}, {""token"": ""IL - 15"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 168, ""end_span"": 180, ""type"": ""Protein""}, {""token"": ""IL - 7R"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Protein""}]"	test
Furthermore, R24 treatment resulted in translocation of c - rel, but little or no NF kappa B p50 or p65, from the cytoplasm to the nucleus and an increase of NF kappa B binding complexes containing c - rel and p50.	c - rel,56,63,Protein	p50,93,96,Protein	p65,100,103,Protein	c - rel,198,205,Protein	p50,210,213,Protein	"[{""token"": ""c - rel"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""c - rel"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 210, ""end_span"": 213, ""type"": ""Protein""}]"	test
Furthermore, the physical interaction of Tax with p100 leads to the inhibition of Tax - induced activation of the HTLV - I and human immunodeficiency virus type 1 long terminal repeats, reflecting p100 - mediated cytoplasmic sequestration of the normally nuclearly expressed Tax protein.	Tax,41,44,Protein	p100,50,54,Protein	Tax,82,85,Protein	p100,197,201,Protein	Tax,275,278,Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""Tax"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""Tax"", ""start_span"": 275, ""end_span"": 278, ""type"": ""Protein""}]"	test
RESULTS: In the OM - 10. 1 promyelocytic model of chronic infection, TNF - alpha - induced HIV - 1 expression also resulted in a substantial increase in 75 kd TNF receptor ( TR75) expression although 55 kD TNF receptor ( TR55) levels were not dramatically altered.	TNF - alpha,69,80,Protein	75 kd TNF receptor,153,171,Protein	TR75,174,178,Protein	55 kD TNF receptor,200,218,Protein	TR55,221,225,Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""75 kd TNF receptor"", ""start_span"": 153, ""end_span"": 171, ""type"": ""Protein""}, {""token"": ""TR75"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Protein""}, {""token"": ""55 kD TNF receptor"", ""start_span"": 200, ""end_span"": 218, ""type"": ""Protein""}, {""token"": ""TR55"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Protein""}]"	test
These inhibitory effects of c - Rel correlate with its DNA - binding activity but not with its ability to heterodimerize with p50, suggesting that c - Rel inhibition involves competition with p50 / p65 for occupancy of the kappa B enhancer element.	c - Rel,28,35,Protein	p50,126,129,Protein	c - Rel,147,154,Protein	p50,192,195,Protein	p65,198,201,Protein	"[{""token"": ""c - Rel"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Protein""}]"	test
Dimerization of NF - KB2 with RelA ( p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B - alpha ( MAD - 3).	NF - KB2,16,24,Protein	RelA,30,34,Protein	p65,37,40,Protein	I kappa B - alpha,114,131,Protein	MAD - 3,134,141,Protein	"[{""token"": ""NF - KB2"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""I kappa B - alpha"", ""start_span"": 114, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""MAD - 3"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Protein""}]"	test
We have previously found that NFKB2 ( p49 / p52) acts in concert with RelA ( p65) to stimulate the HIV enhancer in Jurkat T - leukemia cells.	NFKB2,30,35,Protein	p49,38,41,Protein	p52,44,47,Protein	RelA,70,74,Protein	p65,77,80,Protein	"[{""token"": ""NFKB2"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""p49"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""p52"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Protein""}]"	test
In contrast, the affinity of heterodimeric NFKB2 ( p49) / RelA ( p65) for this site is approximately 6 - fold higher ( KD = 11. 8 pM) than that of p49 alone.	NFKB2,43,48,Protein	p49,51,54,Protein	RelA,58,62,Protein	p65,65,68,Protein	p49,147,150,Protein	"[{""token"": ""NFKB2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""p49"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""p49"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Protein""}]"	test
Thus, LPS activation of human monocytic cells results in nuclear expression of c - Rel / p50 and p50 / p65 ( NF - kappa B) and induces phosphorylation of MAD3.	c - Rel,79,86,Protein	p50,89,92,Protein	p50,97,100,Protein	p65,103,106,Protein	MAD3,154,158,Protein	"[{""token"": ""c - Rel"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""MAD3"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Protein""}]"	test
In this study, we examined the molecular mechanism by which agents that elevate intracellular cAMP inhibit the expression of the tumor necrosis factor alpha ( TNFalpha), tissue factor, endothelial leukocyte adhesion molecule - 1, and vascular cell adhesion molecule - 1 genes.	tumor necrosis factor alpha,129,156,Protein	TNFalpha,159,167,Protein	tissue factor,170,183,Protein	endothelial leukocyte adhesion molecule - 1,185,228,Protein	vascular cell adhesion molecule - 1,234,269,Protein	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 129, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""TNFalpha"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Protein""}, {""token"": ""tissue factor"", ""start_span"": 170, ""end_span"": 183, ""type"": ""Protein""}, {""token"": ""endothelial leukocyte adhesion molecule - 1"", ""start_span"": 185, ""end_span"": 228, ""type"": ""Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 234, ""end_span"": 269, ""type"": ""Protein""}]"	test
We questioned whether or not IL - 10 and IL - 4 affected the expression of transcription factors that are known to be involved in the control of the IL - 6 transcription rate, namely activator protein - 1 ( AP - 1), nuclear factor IL - 6 ( NF - IL6), and nuclear factor kappa B ( NF - kappaB).	IL - 10,29,36,Protein	IL - 4,41,47,Protein	IL - 6,149,155,Protein	nuclear factor IL - 6,216,237,Protein	NF - IL6,240,248,Protein	"[{""token"": ""IL - 10"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""nuclear factor IL - 6"", ""start_span"": 216, ""end_span"": 237, ""type"": ""Protein""}, {""token"": ""NF - IL6"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Protein""}]"	test
NF - IL6 mRNA levels were not affected by IL - 10 or IL - 4, suggesting that IL - 4 affects binding activity of preexisting NF - IL6.	NF - IL6,0,8,Protein	IL - 10,42,49,Protein	IL - 4,53,59,Protein	IL - 4,77,83,Protein	NF - IL6,124,132,Protein	"[{""token"": ""NF - IL6"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""NF - IL6"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Protein""}]"	test
Electrophoretic mobility shift assays showed that IL - 4, but not IL - 10, inhibited nuclear NF - kappaB activity, and that IL - 4 and IL - 10 did not affect NF - IL - 6 activity.	IL - 4,50,56,Protein	IL - 10,66,73,Protein	IL - 4,124,130,Protein	IL - 10,135,142,Protein	NF - IL - 6,158,169,Protein	"[{""token"": ""IL - 4"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Protein""}, {""token"": ""NF - IL - 6"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Protein""}]"	test
DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.	DR3,0,3,Protein	TRADD,96,101,Protein	TRAF2,103,108,Protein	FADD,110,114,Protein	FLICE,120,125,Protein	"[{""token"": ""DR3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""TRADD"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Protein""}, {""token"": ""FADD"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""FLICE"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Protein""}]"	test
Nevertheless, the simian EBV LMP1s retain most functions in common with EBV LMP1, including the ability to induce NF - ( kappa) B activity in human cells, to bind the tumor necrosis factor - associated factor 3 ( TRAF3) in vitro, and to induce expression of tumor necrosis factor - responsive genes, such as ICAM1, in human B lymphocytes.	LMP1s,29,34,Protein	LMP1,76,80,Protein	tumor necrosis factor - associated factor 3,167,210,Protein	TRAF3,213,218,Protein	ICAM1,308,313,Protein	"[{""token"": ""LMP1s"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor - associated factor 3"", ""start_span"": 167, ""end_span"": 210, ""type"": ""Protein""}, {""token"": ""TRAF3"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Protein""}, {""token"": ""ICAM1"", ""start_span"": 308, ""end_span"": 313, ""type"": ""Protein""}]"	test
The Rel / NF - kappa B proteins, p50, p52, p65, c - Rel, and RelB, constitute a family of transcription factors involved in the positive regulation of a variety of genes during the immune response.	p50,33,36,Protein	p52,38,41,Protein	p65,43,46,Protein	c - Rel,48,55,Protein	RelB,61,65,Protein	"[{""token"": ""p50"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Protein""}, {""token"": ""p52"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Protein""}]"	test
S107 plasmacytoma cells, which express CD40 but are defective for the nuclear appearance of p50 / p65 - NF - kappaB, do not express RelB after CD40 stimulation.	CD40,39,43,Protein	p50,92,95,Protein	p65,98,101,Protein	RelB,132,136,Protein	CD40,143,147,Protein	"[{""token"": ""CD40"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Protein""}]"	test
Acetylsalicylic acid and sodium salicylate inhibit LPS - induced NF - kappa B / c - Rel nuclear translocation, and synthesis of tissue factor ( TF) and tumor necrosis factor alfa ( TNF - alpha) in human monocytes.	c - Rel,80,87,Protein	tissue factor,128,141,Protein	TF,144,146,Protein	tumor necrosis factor alfa,152,178,Protein	TNF - alpha,181,192,Protein	"[{""token"": ""c - Rel"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""tissue factor"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""TF"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor alfa"", ""start_span"": 152, ""end_span"": 178, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Protein""}]"	test
